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ABSTRACT
CHARCTERIZATION OF TYPE II TOXIN/ANTI-TOXIN SYSTEMS IN
AGGREGATIBACTER ACTINOMYTEMCOMITANS
By
Blair W. Schneider
March 30, 2018
Microbes express many protective mechanisms in response to environmental
stress. Toxin/anti-toxin systems encode a biologically active toxin and a labile anti-toxin
that inhibits the toxin’s activity. These systems are known to contribute to persister cell
and biofilm formation. A. actinomycetemcomitans thrives in the complex oral microbial
community and is subjected to continual environmental flux. Little is known regarding
the presence and function of TA systems in this organism or their contribution survival in
the oral environment. Using BLAST searches and other informatics tools, we identified
11 intact TA systems that are conserved across all seven serotypes of A.
actinomycetemcomitans and represent the RelBE, MazEF and HipAB families of TA
systems. The A. actinomycetemcomitans TA systems identified selectively responded to
various environmental conditions that exist in the oral cavity. Transcription of two
putative RelBE-like TA systems, D11S_1194-1195 and D11S_1718-1719, were induced
in response to low pH, and were selected for further study. Deletion of D11S_1718-1719
significantly reduced metabolic activity of stationary phase A. actinomycetemcomitans
cells during prolonged exposure to acidic conditions. The mutant also exhibited reduced
biofilm biomass when cultured under acidic conditions. The D11S_1194 and
iv

D11S_1718 toxins inhibited in vitro translation of dihydrofolate reductase (DHFR), and
degraded ribosome-associated, but not free mRNA. In contrast, the corresponding
antitoxins or equimolar mixtures of toxin and antitoxin had no effect on DHFR
production or RNA degradation. Preliminary results comparing the proteomes of acid
stressed mutants to the acid stressed wild-type suggest that metabolism proteins are the
most affected by these two TA systems. Among these, proteins involved in nucleotide
metabolism are largely over-represented in the mutants. Other identified proteins are
directly involved in quorum-sensing, iron transport and virulence (e.g. leukotoxin).
Results of these studies indicate that the anti-toxin proteins inhibit the activity of the
corresponding toxins and suggest that D11S_1194-1195 and D11S_1718-1719 are
RelBE-like type II TA systems that are activated under acidic conditions. The toxins of
both systems may function to cleave ribosome-associated mRNA to inhibit translation in
A. actinomycetemcomitans.
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CHAPTER ONE: INTRODUCTION
Periodontal Diseases
As far back 1500 BCE physicians were aware that infections within the mouth
could lead to death if not treated properly (Olsen et al 2014). Though techniques and
understanding have progressed over the centuries, dental care hit a setback in the late 19th
century as dentists frequently removed all teeth, no matter how severe the infection or the
number of teeth actually affected (Olsen et al 2014). In the late 1980s, the correlation
between oral health and systemic health re-entered the minds of the general public as oral
infections became associated with the conditions, such as cardiovascular disease,
complications during pregnancy (including premature birth), and respiratory infections.
During this time, we also started to see a rise in a class of immuno-compromised patients,
for example, due to infection with HIV virus and chemotherapy treatments for cancer,
which were at an increased risk for uncommon infections.
Periodontal diseases are a group of inflammatory diseases of the periodontium,
the tissues surrounding the teeth (Albandar 2014). The initial stage of periodontal disease
is gingivitis, which is characterized by swelling and bleeding of the gingival tissue
(Armitage 1995). At this point, gingivitis is reversible with proper oral hygiene. If left
untreated, the disease progresses into a chronic inflammatory condition called
periodontitis. Periodontitis is characterized by persistent inflammation that leads to the
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destruction of the supporting tissues surrounding teeth, resulting in recession of the
gingiva and resorption of the alveolar bone. If still left untreated, the affected teeth will
eventually be lost. At this point, proper treatment is necessary and it can involve
antibiotic treatments, mechanical debridement of the area, and oral surgery (Dorfer 2003,
Teughels et al 2014).
Periodontal diseases are prevalent world-wide in both children and adults (Figure
1). In the United States, approximately half of the adult population has some form of the
disease and nearly 1% of children and young adults are affected by aggressive
periodontitis (Susin et al 2014, Eke et al 2015). In the USA, approximately $14.3 billion
was spent on periodontal dental care in 1999 and expenditures increased to $81 billion in
2006, not including the cost of oral hygiene products found in stores (Brown et al 2001,
Beikler et al 2010). It is also estimated that dental patients pay approximately 45% of
associated costs out of pocket, which is about four times more than the cost of seeing a
physician (Mariotti et al 2015). The high cost of treatment, both preventive and reactive,
could possibly explain why only 40% of American adults visit the dentist regularly
(Mariotti et al 2015). In addition to the high cost, many other risk factors can increase an
individual’s likelihood of developing one of the diseases. Risk factors include genetics,
smoking, other illicit drug use, nutrition, and socio-economic status.
Socio-economic status has significant impact on the overall progression of disease
due to lack of access to care and/or poor education in oral healthcare procedures. It is
estimated that more than 47 million Americans do not have regular access to dental
treatment. These Americans are typically low-income, racial minorities, elderly, or from
a rural community with a variety of reasons for not seeing a doctor (Mariotti et al 2015).
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periodontitis world-wide. Red countries have high incidence rates whereas blue counties have low incidence rates.

Figure 1. Prevalence of severe chronic periodontitis world-wide. In 2010, age-standardized prevalence of severe

For example, cultural differences can influence how people respond to illness, such as a
religious opposition to modern medicine. Genetic backgrounds can also increase
disposition to illness, e.g., people of African descent tend to have higher rates of
aggressive periodontitis when compared to other ethnicities. Another important risk
factor is tobacco and illicit drug use. Tobacco users are more susceptible to periodontal
diseases, and they often have more severe disease (Shekarchizadeh et al 2013). With the
growing opiate epidemic nationwide and marijuana use becoming main-stream, more
evidence is becoming available about the effects of these drugs on the oral cavity. Heroin
users experience a variety of oral problems, but usually in the form a unique caries
pattern, in addition to generalized periodontal diseases, while marijuana users may
experience early onset of periodontitis that is dependent on how often they smoke the
substance (Shekarchizadeh et al 2013).
Periodontitis can be classified in a variety of ways, including chronic, necrotizing,
or aggressive, as well as localized or generalized. Aggressive periodontitis, unlike the
other forms, typically develops early in life and has historically been associated with
children near puberty (Albandar 2014). First described more than 40 years ago,
aggressive periodontitis is unique from chronic periodontitis for a number of reasons,
including the age of onset (younger than 25 years old), the high rate of disease
progression, and no systemic conditions that affect the host’s immune response (Albandar
2014). Unlike some of the other periodontitis types, aggressive periodontitis is often
associated with elevated counts of certain bacterial species, such as Aggregatibacter
actinomycetemcomitans and Porphyromonas gingivalis, as well as several of the
herpesviruses (Kononen et al 2014). Prevalence of aggressive periodontitis varies around
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the world, with 0.1% in Swiss children to 3% Sudanese children being afflicted (Susin et
al 2014).
Periodontal diseases are described as inflammatory diseases. Upon colonization of
the oral cavity, the host innate immune system detects and responds to the microbes.
Similar to the gastrointestinal tract, the biofilm within the oral cavity is necessary for
health, which means that the periodontal tissues will constantly have a low-grade immune
response in the area to maintain the biofilm (Kulkarni et al 2014). In the progression of
periodontal disease, there is shift in the immune response from cell-mediated to humoral.
In aggressive periodontitis, however, there is an increase in the number of T-cells and a
decrease in the macrophage population, as well over-activated neutrophils in the blood
and potentially defects in the neutrophil chemotaxis (Kulkarni et al 2014).

Biofilms
The microbiota within in the oral cavity is typically found in a biofilm, and is
commonly called dental plaque. The formation of this biofilm is dependent upon the
presence of glycoproteins coating the tooth surface that are derived from the saliva of the
host, referred to as a pellicle (Huang et al 2011, Mahajan et al 2013). Early colonizing
bacteria adhere to this saliva-derived film. As these bacteria begin to grow, an
extracellular matrix is produced that stabilizes the biofilm by aiding in further attachment
and enhancing bacterial communication. During this time, both the extracellular matrix
and the adherent bacteria provide additional sites for additional bacterial species to
adhere and join the biofilm, culminating in a mature microbial community (Figure 2).
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saliva to spread a new site. Copyright permission to reproduce figure granted by Landes Bioscience and Huang et al .2011.

sites and join the biofilm. (D) Dispersion. Bacteria detach from the biofilm due to death, or lack of nutrients or force from the

pellicle. The adhesion is reversible at this point. (C) Maturation. As bacteria, late colonizing bacteria recognize additional binding

glycoproteins and contents of the saliva. (B) Initial adhesion. Early colonizing bacteria recognize the binding proteins on the

Figure 2. Oral biofilm formation. This diagram represents each step of oral biofilm formation. (A) Pellicle formation due to

During this maturation process, more than 700 different species of bacteria may
colonize the oral biofilm. As cell density increases, the extracellular matrix changes
(secreted proteins, compounds, and extracellular DNA accumulate), a gradient of oxygen
and nutrients forms, and ultimately, biofilm cells are dispersed to the planktonic state
(Huang et al 2011, Mahajan et al 2013). Dispersion occurs when cells, both alive and
dead, are released from the biofilm, by both active and passive processes (i.e. due to lack
of sufficient nutrients or by the shear force of the saliva flowing across the tooth surface)
and these cells can colonize other tissue or tooth surfaces, or may be cleared from the oral
cavity. Importantly, bacterial cells in a biofilm take on phenotypic traits that are markedly
different from characteristics seen during planktonic growth. For example, Pseudomonas
aeruginosa is a well-known opportunistic pathogen that is associated with biofilms on
medical implants. Many early studies showed that Pseudomonas aeruginosa was resistant
to antibiotics when grown in a biofilm, due to the inability of the antibiotic to disseminate
into the extracellular matrix, resulting in an antibiotic gradient (Anwar et al 1989,
Holmes et al 1989, Hoyle et al 1990, Hoyle et al 1991).
Since the extracellular matrix can act as a passive defense mechanism by limiting
outside environmental influences on the biofilm, it also stands to reason that the
extracellular matrix can form other gradients that will have influences on biofilm growth
and which bacteria can adhere (Huang et al 2011, Mahajan et al 2013, Amarasinghe et al
2009). For example, the pH in crevicular fluid can vary depending on health of the
sample site and food consumption, yet many species of bacteria within the oral cavity are
sensitive to pH fluctuation (Bickel et al 1985, Eggert et al 1991, Kleinberg et al 1969). If
a person frequently eats and drinks foods with high simple sugar content, the bacteria
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within the oral cavity will produce massive amounts of lactic acid and other organic
acids. This results in a shift of the pH in the biofilm, which will eventually lead to the
elimination of acid sensitive bacteria. This shift in biofilm composition will allow the
acid-tolerant bacteria, such as Streptococcus mutans, to survive and proliferate, which
can result in the erosion of the tooth enamel, resulting in dental caries (Socranksy et al
2005, Hajishengallis et al 2012).
General studies looking at the biofilm composition of healthy and diseased oral
cavities showed that certain species of bacteria are found in increased numbers in the
diseased mouth. This suggests that disease is caused by a shift in biofilm composition,
and may result in loss of normal host-microbe homeostasis (i.e. dysbiosis). If left
untreated, disease progresses and bacteria can disseminate to have systemic effects.
Multiple studies have shown that there is correlation between oral health and many
systemic diseases, such as diabetes, endocarditis, brain and lung abscesses, rheumatoid
arthritis and osteomyelitis (Yew et al 2014, Pyysalo et al 2016, Hagiwara et al 2009,
Konig et al 2016, Sharma et al 2017).

Aggregatibacter actinomycetemcomitans
A. actinomycetemcomitans is a gram-negative, non-spore forming, non-motile,
facultative anaerobic coccobacillus commensal that is commonly located within the oral
cavity (Figure 3). A. actinomycetemcomitans was first isolated in 1912 from an oral
lesion, it was not considered a member of oral microbiota until 1975 (Klinger 1912,
Kilian et al 1975). Although it is generally considered a commensal, it has the potential
to be an opportunistic pathogen. A. actinomycetemcomitans has been associated with
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et al 1999.

colony phenotype. Copyright permission to reproduce figure granted by Society for General Microbiology and Fine

star-like structure. The bacteria can spontaneously mutate to lose the fimbriae and the colonies exhibit a smooth

initially isolated from the oral cavity and cultured on solid medium, it grows as a rough colony with a characteristic

Figure 3. Characteristics of clinical isolates of A. actinomycetemcomitans. When A. actinomycetemcomitans is

many systemic conditions, such as aggressive periodontitis, endophthalmitis,
endocarditis, urinary tract infections, rheumatoid arthritis, and brain abscesses (Binder et
al 2003, Yew et al 2014, Townsend et al 1969, Konig et al 2016, Pyysalo et al 2016).
A. actinomycetemcomitans, like many pathogens, expresses several virulence factors
that aid its ability to survive within the host. The leukotoxin is a protein that is directly
associated with disease progression in some populations. Leukotoxin is a protein of the
RTX family (repeats in toxin) that binds to leukocytes to induce apoptosis (Raja et al
2014, Taichman et al 1980, Yamaguchi et al 2004, Korostoff et al 2000). Studies have
shown that a specific strain of A. actinomycetemcomitans, strain JP2, is highly associated
with aggressive periodontitis. This strain has a deletion in the promoter region of the
leukotoxin gene that results in high-level expression of this protein. Leukotoxin is unique
among other RTX-family proteins due to the fact that the leukotoxin has a specific target
(LFA-1), which allows it to target polymorphonuclear leukocytes, monocytes and T-cells
(Spitznagel et al 1991, Brogan et al 1994, Hritz et al 1996, Taichmann et al 1986,
Henderson et al 2002, Raja et al 2014). Strains of A. actinomycetemcomitans that express
high levels of leukotoxin also tend to secrete more vesicles, which can contain the
leukotoxin and actinobacillin, which is a bacteriocin produced by A.
actinomycetemcomitans that inhibits the growth of other bacterial species (Henderson et
al 2002, Raja et al 2014, Stevens et al 1987, Hammond et al 1987, Oldak et al 2017).
Other virulence factors include a catalase, IgG protease, ompA-like proteins,
cytolethal-distending toxin, a chemotaxis inhibitor, a capsular polysaccharide
biosynthetic enzymes, and fimbriae (Raja et al 2014). The cytolethal distending toxin is
believed to suppress the host immune response by interfering with the cell division cycle
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(Henderson et al 2002). OmpA proteins in E. coli have been associated with virulence; in
the case of A. actinomycetemcomitans, Omp34 binds to the IL-10 receptor to modulate
monocyte function (Henderson et al 2002). Capsular polysaccharides are generally
associated with the ability of a bacterium to evade the host immune response (i.e. by
inhibiting the complement cascade, and mimicking host antigens) (Agarwal et al 2014,
Cress et al 2014). There are currently seven recognized serotypes of A.
actinomycetemcomitans and an unusual sugar, 6-deoxy-D-talose is found in many of the
serotypes, but its function is currently not known (Henderson et al 2002, Nakano et al
2000, Suzuki et al 2000). The fimbriae are important for disease as well as general
survival within the oral cavity because they aid in adherence to tissues and biofilm
formation, however, the presence of fimbriae is not the sole determining factor for
biofilm formation.
A. actinomycetemcomitans is also unique in that it prefers to utilize a carbon
source that does not result in the highest growth rates. Instead, the organism
preferentially utilizes lactate that is present in the biofilm extracellular matrix, but not
utilized by many of the bacterial species found within the oral cavity (Brown et al 2007).
It is not currently clear why A. actinomycetemcomitans prefers to use this growth limiting
carbon source even in the presence of other carbon sources, such as glucose. As
mentioned previously, many of the bacteria within the oral cavity can utilize simple
sugars from the host’s diet to produce lactic acid as a by-product. With an abundance of
lactate within the extracellular matrix and high competition for the simple sugars, it is
plausible that A. actinomycetemcomitans evolved to prefer the carbon sources that are
readily available in the gingival crevice.
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Competition for nutrients in the biofilm can affect the composition and health of
the bacterial community. One common limiting growth factor for many bacteria within
the human body is iron. Many bacteria utilize siderophores that can be secreted to
scavenge iron from extracellular sources, but A. actinomycetemcomitans does not encode
any of the genes commonly associated these iron-acquiring systems (Rhodes et al 2006).
Common sources of iron sources found in the human host include lactoferrin,
hemoglobin, and transferrin, however, A. actinomycetemcomitans is not able to utilize
these sources either (Rhodes et al 2006). Further experimental assays eventually revealed
that A. actinomycetemcomitans is able to utilize hemin using a TonB-ExbB-ExbD-like
system, as well as inorganic iron using a periplasmic-binding protein-dependent transport
system (Rhodes et al 2006). A more recent study showed that A. actinomycetemcomitans
may internalize host derived catecholamines, which can function as pseudo-siderophores
by scavenging iron from host-derived chelators, such as lactoferrin (Figure 4; Weigel et
al 2015, Freestone et al 2000, Sandrini et al 2010).
Living in a multi-species biofilm presents a multitude of stimuli to the bacteria. It
has been suggested that the progression of periodontal diseases is linked to the formation
of the dental plaque and a shift in the biofilm composition at the inflamed sites (Kononen
et al 2014). For example, A. actinomycetemcomitans can be detected in heathy children at
all ages in very low numbers. There are multiple studies that suggest this number
increases in patients that exhibit localized aggressive periodontitis.
A. actinomycetemcomitans was one of the first oral pathogens to be examined for
production of the quorum-sensing signal, autoinducer-2 (AI-2). Previous studies showed
that A. actinomycetemcomitans contained the genes necessary to produce AI-2 (Blehert
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greater increase. Copyright permission to reproduce figure granted by Molecular Oral Microbiology and Weigel et al

and norepinephrine (Ne/Fe2+). Iron alone caused an increase in optical density, and iron with the catecholamine had a

was grown in a chemically defined medium either alone (CDM), with FeCl2,(Fe2+), norepinephrine (Ne), or both iron

Figure 4. Effects of catecholamines and iron on the growth of A. actinomycetemcomitans. A.actinomycetemcomitans

et al 2003, Fong et al 2001, Frias et al 2001, McNab et al 2003, Novak et al 2010, Wen
et al 2004). The AI-2 pathway in A. actinomycetemcomitans has been shown to regulate
biofilm formation, leukotoxin expression as well as iron acquisition genes, all of which
affect the virulence of the bacteria (Fong et al 2003, Shao et al 2007). Previous research
in our laboratory using A. actinomycetemcomitans showed that the AI-2 induces the
expression of the QseBC two-component system (Novak et al 2010). In E. coli, QseBC is
a quorum sensing regulator for the motility genes and deletion of qseB resulted in a large
descrease in biofilm mass (Gonzalez et al 2006). Figure 5 shows results of an assay in E.
coli that suggests that the a functional MqsR protein is needed for biofilm formation and
Gozalez et al were also able to show that deletion of the mqsR also resulted in a reduction
in the transcription of qseB as well as more than 40 other genes by acting as a global
regulator of gene transcription (Gonzalez et al 2006, Yamuguchi et al 2009). A mqsRlike gene has also been identified in A. actinomycetemcomitans (Novak et al 2010).
MqsR is part of a two-gene operon that has been associated with biofilm
formation, motility, and persister cell phenotype (Karimi et al 2014, Merfa et al 2016,
Kim et al 2010). MqsRA has previously been shown to be a global gene regulator that
can inhibit bacterial growth and protein translation in vivo (Kasari et al 2010).
Expression of this protein does not lead to cell death immediately, but rather enables the
cells to survive for a short period when exposed to environmental stress.
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B) E. coli with AI-2 added C) E. coli strain MG1655 D) MG1655 with mqsR deleted. Copyright

Figure 5. Effects of AI-2 and mqsR on biofilm formation. A) E. coli biofilm control with no AI-2

Toxin/Anti-Toxin Systems
MqsR has since been determined to be a protein that functions as a sequencespecific mRNA interferase (Yamaguchi et al 2009). MqsR has also been shown to be part
of a small, two gene operon called a toxin/anti- toxin (TA) system. Unlike many other
proteins that are called toxins, the toxin is only toxic within the bacterial cell; it is not
intended to kill other bacteria or host cells. Toxins are often co-expressed with their
associated anti-toxin. As the name implies, the anti-toxin acts on the toxin to inhibit its
function. There are currently six recognized classes of TA systems that are differentiated
from each other based on how the anti-toxin interacts with the toxin (Kedzierska et al
2016, Mruk et al 2014).
In all classes of TA systems, the toxin is a protein that can act within the cell in a
variety of modes to alter gene expression. The anti-toxin is usually labile and it does not
need to be a protein to inhibit the toxin (Figure 6). In type I systems, the anti-toxin is an
anti-sense RNA that binds directly to the toxin’s mRNA preventing its translation. In type
II systems, the anti-toxin is a protein that binds directly to the toxin’s protein to inhibit
function. In type III systems, the anti-toxin is an RNA that binds directly to the toxin
protein to inhibit its function. In type IV systems, the anti-toxin is a protein that binds to
the target of the toxin rather than the toxin itself. In type V systems, the anti-toxin is a
protein that cleaves the mRNA of the toxin to inhibit its translation. In type VI systems,
the anti-toxin acts as a protease adaptor to enable toxin protein degradation, which is not
shown in the Figure 6 (Kedzierska et al 2016, Mruk et al 2014). There are also types of
restriction-modification systems (Figure 6) that share many similarities to the TA
systems.
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Figure 6. Types of TA systems. In all cases, the toxin itself is a protein. Type II
restriction-modification system anti-toxins methylate the genomic DNA to protect it from
cleavage by the toxin. Type I TA system anti-toxin is an antisense RNA that binds
directly to the toxin’s mRNA. Type II TA system anti-toxin is also a protein that binds
directly to the toxin protein. Type III TA system anti-toxin is RNA that binds to the
protein toxin. Type IV TA system anti-toxin is a protein that binds to the target of the
toxin. Type V YA system anti-toxin is a protein that cleaves the toxin mRNA. In the
diagram above, A is anti-toxin; T is toxin. Copyright permission to reuse is granted by
Creative Commons Attribution Non-Commercial License and the authors (Mruk et al
2014).
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Type I and II systems are widely found among the entire prokaryotic world. In
fact, many species contain multiple copies and many species contain no copies. There is
growing evidence that TA systems respond to environmental cues to arrest cell growth.
The advantage of these systems is that if environmental conditions are unfavorable to
growth, such as lack of a carbon source, the toxins can temporarily stop cell growth
without killing the cell until conditions become favorable. As some species contain
multiple copies, it is theorized that different systems will respond to different stress
conditions (Ghafourian et al 2014, Kedzierska et al 2016, Mruk et al 2014). With the
type II TA systems, there are at least ten families of systems that are classified based on
how the toxin functions (Table 1). Many of the systems, but not all, directly affect gene
expression either by directly regulating translation, but also indirectly by acting as gene
regulators.
Type II TA systems have been recently investigated as potential therapeutic
targets. Possible applications include, artificial activation of the toxin since prolonged
exposure to stress will lead to cell death, and the mass production of the toxin itself.
Utilizing the bacteria’s own defense systems could prove to be a low-cost, non-invasive
method to treat certain infections (Lee et al 2016).
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Table 1. Type II TA system families. There are currently ten recognized families of
type II systems that all function to control cell growth and activity (Bukowski et al 2011,
Ghafourian et al 2014, Mruk 2014, Van Melderen et al 2009).
Family

Activity

Mechanism of Toxicity

ccdAB

Gyrase inhibitor

Transcription inhibition

parDE

Gyrase inhibitor

Transcription inhibition

Phd/doc

Binds 30S ribosomal subunit

Translation inhibition

maxEF

Endoribonuclease

Translation inhibition

RelBE

Ribosome-binding endoribonuclease

Translation inhibition

higAB

Ribosome-binding endoribonuclease

Translation inhibition

vapBC

Endoribonuclease

Translation inhibition
Peptidoglycan biosynthesis

ζε

Phosphotransferase

hipAB

Serine/Threonine Kinase

Translation inhibition

hicAB

Endoribonuclease

Translation inhibition

inhibition
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Type II Toxin/Anti-Toxin Systems and A. actinomycetemcomitans
The genome for A. actinomycetemcomitans encodes approximately 1877 openreading frames, with 32% having no known function. Among those unknown genes, 6%
are unique to A. actinomycetemcomitans (Henderson et al 2003). Previous work in the lab
suggests A. actinomycetemcomitans contains at least one type II TA system. More
evidence that these systems may exist and function in A. actinomycetemcomitans is
indicated by a number of studies.
One general study looked at the effects of temperature and pH on the protein
expression of A. actinomycetemcomitans (Goulhen et al 2003). This study showed that
each of the stress conditions showed different protein expression patterns, with some
proteins being more abundant and others being less abundant. Since it has been suggested
that bacteria contain multiple TA systems to adapt to changing environmental stress
conditions, it is possible that multiple TA systems exist within A. actinomycetemcomitans
that respond differentially to stress. Another study determined viability of A.
actinomycetemcomitans across a pH range (Bharracharjee et al 2011). By storing and
passaging stationary phase bacteria, Bharracharjee et al showed a decrease in viability
over time. As A. actinomycetemcomitans grows to stationary phase, the pH of the
medium becomes acidic. However, if the pH of spent medium was adjusted to neutral,
then the cells would continue to grow without added nutrients. Since stationary phase is
not necessarily a marker for bacterial cell death, it is possible that the bacteria are able to
survive for a period of time in the unfavorable environmental conditions before dying.
Most strains of A. actinomycetemcomitans contain a gene that encodes for a
catalase and certain strains are highly resistant to killing by hydrogen peroxide (Miyasaki
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et al 1986). Miyasaki et al did not investigate gene expression changes as a result of the
reactive oxygen species stress, however, a study in C. crescentus suggests that ParDE and
RelBE TA systems can and do respond to general oxidative stress. Another study in M.
smegmatis showed that a ParDE-like system also responded to oxidative stress (Fiebig et
al 2010, Gupta et al 2016). As mentioned previously, A. actinomycetemcomitans prefers
to use lactate as a carbon source when it is present. The utilization of lactate inhibits the
transport of glucose into the bacterial cell, so it is possible that the gene expression
changes responsible for this reaction are due to TA system activation (Brown et al 2007).
Finally, certain isolates of A. actinomycetemcomitans have been shown to invade
epithelial cells (Henderson et al 2003). This drastic change in environment could also
activate TA systems to ensure survival of the bacteria within the host cell in a variety of
ways, including increasing the likelihood of persister cell formation (Helaine et al 2014,
Cardenas-Mondragon et al 2016).
At present, the presence of type II TA systems in A. actinomycetemcomitans has
not been investigated. Based on previous work down within the laboratory, it is
hypothesized that A. actinomycetemcomitans contains multiple type II TA systems and
that these systems aid in the adaptation and survival of the organism with the oral cavity.
Understanding how oral bacteria, especially the pathogens, survive within the oral cavity
in the constantly fluctuating environment will help researchers develop novel therapies
for pathogens, including A. actinomycetemcomitans, that utilize type II TA systems for
survival that will be cost-effective and less invasive to the patient.
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CHAPTER TWO: MATERIALS AND METHODS

Bacterial strains, plasmids, and media. The bacterial strains and plasmids used
in this study are listed in Table 2A-D. Luria-Bertani (LB) broth and LB agar (LB broth
plus 1.5% agar) were routinely used for the propagation and plating of E. coli. Bacteria
were grown at 37oC in either a shaking incubator for planktonic growth or a
microaerophlic (5% CO2) incubator for plates. Brain-heart infusion (BHI) broth and BHI
agar (BHI plus 1.5% agar), Super Optimal Broth with Catabolite repression (SOC; 2%
tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, and 20 mM
Glucose) and Tryptone-Yeast Extract Broth (TYE; 1% tryptone and 0.5% yeast extract)
and TYE agar (TYE plus 2% agar) were routinely used for the propagation and plating
A. actinomycetemcomitans, A. actinomycetemcomitans strain 652 is afimbriated and was
grown at 37oC under microaerophilic conditions, either in a candle jar for plates or in an
incubator with 5% CO2 for broth cultures. In some assays, A. actinomycetemcomitans
was grown in chemically defined medium (CDM) as described by Socransky et al. (1985)
with some modifications (Table 3A-B). In some assays, the pH of the broth was adjusted
to various points between 5.0 and 8.0. When necessary, medium was supplemented with
25 ug mL-1 kanamycin, 50 ug mL-1 spectinomycin, 12.5 ug mL-1 tetracycline, 50 ug mL-1
ampicillin, 40% sucrose or 1mM isopropyl B-D-1-thiogalactopyranoside (IPTG).

22

Identification of putative TA systems. Putative type II toxin/anti-toxin (TA)
systems in A. actinomycetemcomitans were identified by two methods. First, the genome
of A. actinomycetemcomitans strain D11S-1, a serotype c strain that is related to strain
652, (Chen et al 2009) was probed for sequence similarities to known E. coli TA systems
using the protein basic local alignment search tool (pBLAST; NCBI). The sequences for
known toxins that were used in these BLAST searches are listed in Table 4. Next, the
entire genome of A. actinomycetemcomitans strain D11S-1 was examined using TAfinder
(http://202.120.12.133/TAfinder/TAfinder.php) to identify operons composed of two
small genes that were not previously identified in the BLAST searches. TA Finder
detects type II TA loci based on sequence alignments and conserved domain searches
against a database of known TA families. The genes that were identified as putative TA
systems in strain D11S-1 were subsequently used to probe 33 other A.
actinomycetemcomitans genome sequences, representing all seven serotypes that were
present in the NCBI database (Table 5).
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Table 2A. A. actinomycetemcomitans strains used in this study
Bacterial strain

Description

Source

652

Wild-type, serotype C

Laboratory Strain

652-BWS1

652 Δ1194-1195

This study

652-BWS2

652 Δ1718-1719

This study

652-BWS1C

652 Δ1194-1195::1194-1195

This study

652-BWS2C

652 Δ1718-1719::1718-1719

This study

Table 2B. Escherichia coli strains used in this study
Bacterial strains

Description

Source

XL1-Blue MRF1

Δ(mcrA)183 Δ(mcrCB-hsdmSMR-mrr)173
endA1 supE44 thi-1 recA1 gyrA96 relA1
lac[F' proAB. lacIqZΔM15 Tn10 (Tcr)]

Stratagene

One Shot Top10

F- mcrA Δ( mrr-hsdRMS-mcrBC)
Φ80lacZΔM15 Δ lacX74 recA1 araD139
Δ( araleu)7697 galU galK rpsL
(StrR) endA1 nupG
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Thermo Fisher
Scientific

Table 2C. Plasmids for A. actinomycetemcomitans
Plasmid

Description

Source

pJT1

SpR suicide vector

Juárez-Rodríguez 2013b

pJT4

KmR promoterless expression vector

Juárez-Rodríguez 2013b

pBWS1

pJT1 derived, 1194-1195

This study

pBWS1

pJT1 derived, 1718-1719

This study

pBWS1C

pJT4 derived, 1194-1195

This study

pBWS2C

pJT4 derived, 1718-1719

This study

Table 2D. Plasmids for E. coli
Plasmid

Description

Source

pQE60

AmpR expression plasmid with C-terminal
6X His-tag, multiple cloning site and T5
promoter/lac operator, T5 transcription
start

Qiagen

p1194

pQE60 derived, 1194

This study

p1195

pQE60 derived, 1195

This study

p11TA

pQE60 derived, 1195-1195

This study

p1718

pQE60 derived, 1718

This study

p1719

pQE60 derived, 1719

This study

p17TA

pQE60 derived, 1718-1719

This study
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Table 3. CDM composition
Concentration

Concentration

Chemical/Compound

Chemical/Compound
(mg/L)

(mg/L)

ZnSO4

0.7

L-Serine

100

KI

0.1

L-Lysine HCl

100

CuSO4

0.065

L-Histidine

135.1

Boric Acid

0.5

L-Glutamine

100

MgSO4 · 7 H2O

700

L-Asparagine

113.6

FeSO4 · 7 H2O

5

L-Methionine

100

MnSO4

5

L-Isoleucine

100

NaCl

100

L-Proline

100

K2PO4

200

L-Aspartic Acid

100

CaCl2

100

L-Phenylalanine

100

KH2PO4

1000

L-Tyrosine
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NaMo4

0.5

L-Cystine

5

KNO3

100

L-Ornithine HCl

20

L-Glutamic Acid

249.6

L-Hydroxyproline

20

DL-Alanine

200

Adenine

12.5

L-Leucine

100

Guanine

10

Glycine

100

Cytosine

13.5

L-Valine

100

Thymine

10

L-Tryptophan

100

Xanthine

10

L-Threonine

100

Hypoxanthine

10
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Table 3 (continued). CDM Composition
Concentration

Concentration

Chemical/Compound

Chemical/Compound
(mg/L)

(mg/L)

Uracil

10

D-Biotin

0.1

Choline Chloride

50

DL-6,8-Thioctic Acid amide

0.1

Β-Alanine

10

Vitamin B12

0.01

Pyridoxal

1

NaHCO3

1000

Pyridoxine HCl

1

L-Cysteine

650

Pyridoxamine · 2HCl

1

Glucose

3600

Spermidine · 3 HCl

1

Nicotinic Acid

1

Magnesium L-Lactate*

4050

Nicotinamide

1

Calcium Pentothenate

1

Spermine · 4 HCl

1

Thiamine HCl

1

Myo-inositol

10

Nicotinamide adenine

1

dinucleotide
p-Aminobenzoic Acid

0.1

Pimelic Acid

0.1

Folic Acid

1

Riboflavin

1

*MgSO4 was not added with lactate
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Table 4. Protein sequences used for BLAST searches
Toxin

Toxin Sequence (protein)

ccdB

mqfkvytykr esryrlfvdv qsdiidtpgr rmviplasar llsdkvsrel ypvvhigdes wrmmttqmvs vpvsvigeev
adlshrendi knainlmfwg i

parE

mlpvlwlesa dtdldditsy iarfdidaae rlwqrlrgcv lplsehpyly ppsdrvpglr eivahpnyii lyrvttssve
vvnviharrq fp

phD

mqsinfrtar gnlsevlnnv eageeveitr rgrepavivs katfeaykka aldaefaslf dtldstnkel vnr

mazF

mvsryvpdmg dliwvdfdpt kgseqaghrp avvlspfmyn nktgmclcvp cttqskgypf evvlsgqerd
gvaladqvks iawrargatk kgtvapeelq likakinvli g

chpK

mtrgeiwwvd lgipfgsepg fqrpvlivqn nafnhsnint iivvplttnl hlatapgnsm lkkedtnlsk dsivnvsqiv
tidrerfikk vteiknkhmk kveegmklvl sles

kid

xergeiwlvs ldptagheqq gtrpvlivtp aafnrvtrlp vvvpvtsggn fartagfavs ldgvgirttg vvrcdqprti
dmkarggkrl ervpetimne vlgrlstilt

pemK

mlkyqlknen gwmhrrlvrr ksdmergeiw lvsldptagh eqqgtrpvli vtpaafnrvt rlpvvvpvts ggnfartagf
avsldgvgir ttgvvrcdqp rtidmkargg rlervpeti mnevlgrlst ilt

chpBK

mvkkseferg divlvgfdpa sgheqqgagr palvlsvqaf nqlgmtlvap itqggnfary agfsvplhce egdvhgvvlv
nqvrmmdlha rlakriglaa devveeallr lqavve

relE

mayfldfder alkewrklgs tvreqlkkkl vevlesprie anklrgmpdc ykiklrssgy rlvyqvidek vvvfvisvgk
rersevysea vkril

yoeB

mkliwseesw ddylywqetd krivkkinel ikdtrrtpfe gkgkpeplkh nlsgfwsrri teehrlvyav tddslliaac
ryhy

ygjN

mhlitqkalk daaekypqhk telvalgnti akgyfkkpes lkavfpsldn fkyldkhyvf nvggnelrvv amvffesqkc
yirevmthke ydfftavhrt kgkk

yafO

mrvfktklir lqltaeelda ltadfisykr dgvlpdifgr dalyddsftw plikfervah ihlanennpf ppqlrqfsrt
ndeahlvycq gafdeqawll iailkpephk lardnnqmhk igkmaeafrm rf

ygiU

mekrtphtrl sqvkklvnag qvrttrsall nadelgldfd gmcnviigls esdfyksmtt ysdhtiwqdv yrprlvtgqv
ylkitvihdv livsfkek
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Table 4 (continued). Protein sequences used for BLAST searches
Toxin

Toxin Sequence (protein)

mqsR

mekrtphtrl sqvkklvnag qvrttrsall nadelgldfd gmcnviigls esdfyksmtt ysdhtiwqdv yrprlvtgqv
ylkitvihdv livsfkek

yafQ

miqrdieysg qyskdvklaq krhkdmnklk ylmtllinnt lplpavykdh plqgswkgyr dahvepdwil iykltdkllr
fertgthaal fg

higB

mhlitqkalk daaekypqhk telvalgnti akgyfkkpes lkavfpsldn fkyldkhyvf nvggnelrvv amvffesqkc
yirevmthke ydfftavhrt kgkk

vapC

mldtnicsfi mreqpeallk hleqsvlrgh rivvsaitys emrfgatgpk asprhvqlvd afcerldavl pwdraavdat
teikvalrla gtpigpndta iaghaiaaca ilvtnnvref ervpglvled wvr

Zeta

manivnftdk qfenrlndnl eelvqgkkav esptafllgg qpgsgktslr saifeetqgn vvvidndtfk qqhpnfdelv
klyekdvvkh atpysnrmte alisrlsdqg ynlviegtgr ttdvpiqtat mlqakgyetk tyamavpkie sylgtierye
tmyaddpmta ratpkqahdi vvknlptnle tlhktglfsd irlynregvk lyssletpsi spketlerel nrkvsgkeiq
ptlerieqkm vqnqhqetpe fkaiqqkmes lqpptppipk tpklpgi

hipA

mpklvtwmnn qrvgeltkla ngahtfkyap ewlasryarp lslslplqrg nitsdavfnf fdnllpdspi vrdrivkryh
aksrqpfdll seigrdsvga vtlipedetv thpimawekl tearleevlt aykadiplgm ireendfris vagaqektal
lrigndwcip kgitptthii klpigeirqp natldlsqsv dneyycllla kelglnvpda eiikagnvra laverfdrrw
naertvllrl pqedmcqtfg lpssvkyesd ggpgiarima flmgssealk drydfmkfqv fqwligatdg haknfsvfiq
aggsyrltpf ydiisafpvl ggtgihisdl klamglnask gkktaidkiy prhflatakv lrfpevqmhe ilsdfarmip
aaldnvktsl ptdfpenvvt avesnvlrlh grlsreygsk

hicA

mgktdkllak flnskktfew delvvlfssl gyvkkemqgs rvrffnaein htilmhrphp esyikggtlk aikqnlkeag ll

yncN

mkqsefrrwl esqgvdvang snhlklrfhg rrsvmprhpc deikeplrka ilkqlgls
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Table 5. Strains of A. actinomycetemcomitans used for BLAST searches
Strain

Serotype

GenBank Accession Number

624

A

CP012959.1

D7S-1

A

CP003496.2

H5P1

A

AEJK00000000.2

D17P-3

A

ADOA00000000.2

A160

A

AJME00000000.2

ANH9381

B

CP003099.1

HK1651

B

CP007502.1

Y4

B

AMEN00000000.1

RhAA1

B

AHGR00000000.1, JPZI00000000.1

SCC1398

B

AEJP00000000.2

I23C

B

AEJQ00000000.2

SCC4092

B

AJMF00000000.2

S23A

B

AJMH00000000.2

D11S-1

C

CP001733.2

SC38S

C

AZTR00000000.1

SCC2302

C

AEJR00000000.2

D17P-2

C

ADOB00000000.2

AAS4A

C

AJMG00000000.2

SA2200

D

AZTY00000000.1

SA269

D

AZTX00000000.1

SA3033

D

AZTW00000000.1
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Table 5 (continued). Strains of A. actinomycetemcomitans used for BLAST searches

Strain

Serotype

GenBank Accession Number

SA3733

D

AZTV00000000.1

SC1083

E

AEJM00000000.1

SA2149

E

AZTT00000000.1

SC936

E

AZTP00000000.1

SA2876

E

AZTS00000000.1

ANH9776

E

AZTZ00000000.1

SA3096

E

AZTQ00000000.1

SCC393

E

AEJN00000000.2

SC29R

F

AZTO00000000.1

D18P1

F

AEJO00000000.2

NUM 4039

G

AP014520.1

31

Expression of putative TA systems under environmental stress. The
expression of the putative TA systems was determined under various environmental
stress conditions using real-time PCR. Cells were grown in CDM supplemented with 20
mM glucose or 20 mM lactate (Brown et al 2007) at 37oC in an aerobic incubator to midlog phase and were subsequently exposed to various environmental stress conditions for
20 minutes. Environmental conditions used were: acidic pH (pH 5.0), oxidative stress
(0.1% hydrogen peroxide), microaerophilic conditions (5% carbon dioxide), elevated
temperature (39oC), anaerobic conditions, iron starvation (250 μM bipyridyl), and
reduced temperature (30oC). Bacteria were then harvested for RNA extraction using the
cesium chloride step-gradient method as described by Reddy et al. (2001). RNA was
reverse transcribed to cDNA using random primers provided in the cDNA synthesis kit
(Quanta Bio), and the resulting cDNA was used in SYBR Green real-time PCR using
primers for the TA system (Table 6A) as recommended by the manufacturer (Quanta
Bio). Data was analyzed using the ΔΔCt method and fold change expression was
determined by normalizing the results to the levels of an unstressed control (5S rRNA
was used for normalization).

Generation of expression plasmids. DNA manipulations were carried out as
described by Juárez-Rodríguez et al. (2013). PCR products were amplified using high
fidelity PCR supermix as recommended by manufacturer (Invitrogen and Alkali Science).
All primers (Table 6B) used in this study were flanked with restriction enzyme
recognition sites. Primers were designed using the genome sequence of A.
actinomycetemcomitans D11S-1 strain available in the NCBI database. Restriction
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enzymes and ligation reactions were used as recommended by the manufacturer (New
England Biolabs). Transformation of both E. coli and A. actinomycetemcomitans was
done by electroporation (2 mm cuvette with 1800 V, 25 uF, 200 Ω). For transformation
of E. coli, ~3 ug plasmid was used for electroporation. Plasmids that were transformed
into A. actinomycetemcomitans were first produced from 25 mL of E. coli harvested for
plasmid extraction using a miniprep kit as recommended by the manufacturer (Qiagen
and Zymo Research) and 20 ug of plasmid were used for each electroporation.
Transformant colonies were recovered in SOC broth for 45 minutes or 5 hours, for E. coli
and A. actinomycetemcomitans, respectively, and then plated on either LB agar or BHI
agar supplemented with appropriate antibiotics. Samples were sent to the DNA
sequencing facility for further confirmation of gene insertion.

Generation of isogenic deletion mutants. The generation of markerless deletion
mutations was carried out as described by Juárez-Rodríguez et al. (2013) with some
modifications. PCR fragments of the upstream and downstream flanking regions for the
genes of interest were amplified by PCR and cloned into the pJT1 suicide vector (Table
6B). pJT1 was first cloned into E. coli cells to ensure propagation of the plasmid.
Colonies showing spectinomycin resistance were analyzed for gene insertion. Plasmids
that were positive for gene insertion were analyzed by restriction digestion for
appropriate size and sent to the DNA sequencing facility for further confirmation. Once
confirmed, plasmid was harvested for use in A. actinomycetemcomitans. Electroporated
cells were recovered in SOC broth for 5 hours before being plated. Colonies that
underwent a single recombination event were selected on the agar using spectinomycin
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resistance. Multiple colonies were selected and sub-cultured in BHI broth with antibiotics
and then passaged into BHI broth lacking antibiotics for a minimum of two days. A final
passage was performed into TYE broth supplemented with IPTG to induce the expression
of levansucrase, encoded by sacB carried on the plasmid vector. Levansucrase is an
enzyme that forms long levan chains from sucrose and is lethal to gram negative bacteria
in the presence of sucrose. The cultures were then serially diluted and plated on TYE agar
supplemented with IPTG and sucrose. A minimum of 100 colonies were replica plated
from the TYE agar plate on to TYE agar plates with IPTG and sucrose and BHI with
antibiotics. Colonies that were sucrose resistant and antibiotic sensitive were selected for
PCR confirmation that the genes of interest were deleted. Colonies that were positive for
deletion were sent to DNA sequencing facility for further confirmation.
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Measurement of metabolic activity. To assay for metabolic activity of isogenic
mutants over time, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay was performed as described by Wang et al. (2010) with some
modifications. Cells were grown to stationary phase, removed from the incubator
(t=0), and stored at room temperature for up to seven days. At each time point, 3 mL of
culture was pelleted, re-suspended in fresh BHI, diluted 1:10 into fresh BHI broth
containing MTT. Cultures were then incubated for two hours (approximately one
doubling period) at 37oC under microaerophilic conditions before being harvested. When
MTT is dissolved, the initial solution is yellow. Cells with metabolic activity will reduce
the MTT via NADH+/NADPH+-dependent oxidoreductase enzymes in the electron
transport chain into water-insoluble formazan (Stepaneko et al 2015). The resulting
formazan crystals were harvested by centrifugation and allowed to air-dry for 30 minutes
before being dissolved in dimethyl sulfoxide (DMSO). Absorbance was read at 550 nm.

Growth and analysis of static biofilms. Static biofilms were grown in multi-well
tissue culture plates (Merritt et al 2005, Haase et al 2006, Izano et al 2008). A.
actinomycetemcomitans cultures were grown in BHI broth overnight and OD600 was
measured. To form mature A. actinomycetemcomitans biofilms, cells were diluted into
fresh BHI broth to a final OD600 of 0.005 and this dilution was used to inoculate the plate
wells. Cultures were incubated at 37oC for 72 hours and the resulting biofilms were
supplied with fresh BHI broth that was pH adjusted from pH 5.0 – pH 8.0 to represent the
entire range of conditions that might exist in the gingival pocket (Kleinberg et al 1969;
Bickel et al 1985; Eggert et al 1991). Biofilms were incubated for an additional 24 hours,
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then rinsed gently with sterile water before staining with 0.1% crystal violet. After
staining, cells were rinsed with sterile water until the water was clear. After drying,
crystal violet was solubilized with 30% acetic acid and the absorbance at OD570 was
measured for each biofilm.

Statistical analysis. All assays were carried out in at least triplicate and data were
analyzed using the unpaired t-test with statistical significance defined as P ≤ 0.05.

Functional analysis of putative TA systems. Individual toxin and anti-toxin
proteins were cloned into pQE60 (Qiagen) for expression and isolation. Recombinant
bacteria were grown in LB broth that was supplemented with ampicillin, tetracycline and
IPTG in a shaking incubator at 37oC until late log phase. Cells were harvested and protein
was extracted as follows: The cell pellet was suspended in a denaturing protein buffer (50
mM phosphate, pH 7.8, 300 mM NaCl, 0.1% SDS) and sonicated on ice with 5 second
bursts until clear. Samples were centrifuged and the supernatant was removed into a clean
tube. The pellet was suspended in denaturing protein buffer and the sonication process
was repeated. After centrifugation for a second time, the supernatant was transferred to a
clean tube. Samples were analyzed via NuPAGE Bis-Tris SDS-PAGE gels (Thermo
Fisher) according to manufacturer instructions. Samples were then transferred to a PVDF
membrane (GE) for a western blot analysis. Membranes were probed with a primary
antibody to the hexa-histidine tag (Takara) according to manufacturer instructions. A
secondary antibody, a horseradish peroxidase conjugate (Sigma) and a 3,3’,5,5’tetramethylbenzidine (TMB) substrate (VWR) was used to visualize samples. As needed,
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samples were affinity purified using cobalt resin (Takara and Goldbio) according to
manufacturer instructions using buffers that were adjusted to a final concentration of
0.1% SDS. Samples were then refolded according to Roussel et al (2013) using 2-methyl2,4-pentanediol (MPD). Samples were concentrated using Vivaspin-20 (Sartorius).
To eliminate the possibility of RNase contamination from protein expression and
production in E. coli, peptides (Table 7) representing the toxin and anti-toxin proteins of
each TA system were chemically synthesized (Biosynthesis Inc.). Synthetic peptides
were dissolved in a protein buffer (0.05M Phosphate buffer, pH 7.8, 300mM NaCl,
0.01% TFA) and peptide purity and size was confirmed using a NuPAGE Bis-Tris SDSPAGE gel (Thermo Fisher). Samples were prepared in NuPAGE LDS Sample Buffer,
Reducing Agent and Antioxidant (Thermo Fisher) and gels were electrophoresed using
NuPAGE MES Buffer (Thermo Fisher) in the XCell SureLock MiniCell as recommended
by manufacturer. To test the ability of the synthetic toxins and anti-toxins to interfere
with protein translation, a cell-free protein synthesis system was used. Toxin (200 ng),
anti-toxin (200 ng), and equal concentrations of both were added to the PURExpress In
Vitro Protein Synthesis Kit (New England BioLabs) using the control plasmid DNA that
expresses dihydrofolate reductase (DHFR). Reactions were incubated in a thermocycler
at 37oC for 2 hours. 5 uL of the reaction was used for analysis on a Tris-Glycine SDSPAGE gel (Thermo Fisher) according to manufacturer’s instructions. All protein
gels were stained with AcquaStain 1-Step Protein Gel Stain (Bulldog Bio) overnight and
destained with sterile water for 20 minutes before imaging. To determine if the toxin and
anti-toxin proteins function to degrade mRNA in the presence of ribosomes,
MS2 bacteriophage genomic RNA (Roche) was mixed with toxin (200 ng), anti-toxin
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(200 ng) or both together in the presence and absence of ribosomes. Reactions were
incubated at 37oC for 30 minutes before the reaction was stopped with RNA loading dye
containing 47.5% formamide (New England BioLabs). Reactions were denatured at 85oC
for 15 minutes before analysis on TBE-Urea gels (Thermo Fisher) according to
manufacturer’s recommendation. Gels were rinsed in DEPC-treated water for 10 minutes
and were stained for 20 minutes with ethidium bromide and rinsed twice with DEPCtreated water before imaging.

Protein-Protein Interactions. To determine if the toxin and associated anti-toxin
bind together, samples were analyzed on a Superdex 75 Increase, 10/300 GL column
according to the manufacturer instructions using a AKTApurifier UPC10 FPLC (flow
rate = 0.5 mL/min, Pressure = 1.25 MPa, Temperature = room temperature). 1 mg of each
peptide was analyzed separately as well as mixed together in HPLC-grade PBS with
0.5% TFA.

Proteomic analysis. Cultures of A. actinomycetemcomitans wild-type and both
isogenic mutants were grown to mid-log phase in CDM. Cells were gently pelleted and
the media decanted. The pellet was suspended in fresh CDM at pH 5.0, and incubated for
4 hours (approximately two doubling periods). The cultures were harvested with gentle
centrifugation and the pellet was suspended in a denaturing buffer (50 mM phosphate
buffer, pH 7.8, 300 mM NaCl, 8M Urea). Samples were sent to the Proteomics Core at
the University of Louisville for analysis. Results were analyzed using the Scaffold
Software (Proteome Software) by comparing the number of hits for a given protein
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sequence between a mutant and wild-type as well as between the both mutants. Limits
were set to only examine sequences that were present at least twice within a given
sample. The resulting ratio (mutant vs wild-type) indicates a fold-change in abundance in
the mutant as it relates to the wild-type. A number greater 1.0 indicates that the protein
was found more frequently in the mutant than in the wild-type whereas a number below
1.0 indicates that the protein was found less frequently in the mutant
Proteins that were differentially represented were analyzed using the Pfam (Finn
et al 2016) and String Protein-Protein Interaction Networks Database (ELIXIR
infrastructure) to determine the function, when possible, of each protein and what other
pathways may be affected by the gene of interest.

Table 7. Peptide sequences for toxins and anti-toxins.
Protein

Sequence

M.W.

D11S_1718

MNVISYSAFRAELATTLDQVVADHSPVMITRQNGKHAVVMSLEDFAA
YEETAYLLRSPKNRERLLASIDQLNSGKIIERELQE
MILAWTETAWEDYLYWQQVDKKTLLRINKLIQNITRAPFEGLGNPEPL
KHQLSGFWSRRIDKEHRLVYQVSDSHLTIIQCRYHY
MDYVLSKEYKRDLKKLPVEIQSGPEYAEVLYCLFNQKSLPERYKDHALQ
GNWQGFRDCHIKNDLILIYKIEADTLYFARLNSHSEVFK
MLDSAVNFRTQADIKEQAFNVIKSYGLTPAQVLNMFLTQIAKTNTIPLS
LDYQPNTKTANAINELMSGKGERFSVDSFDEFQQKMRDLSK

9394.6

D11S_1719
D11S_1194
D11S_1195
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10201.6
10515.9
10165.5

CHAPTER THREE: IDENTIFICATION AND CHARACTERIZATION OF PUTATIVE
TYPE II TOXIN/ANTI-TOXINS IN AGGREGATIBACTER
ACTINOMYCETEMCOMITANS

Introduction
Microbes have evolved many mechanisms to detect and respond to environmental
cues. Type II toxin/anti-toxin (TA) systems are small gene systems that encode a
biologically active protein, the toxin, and a labile protein, the anti-toxin, that prevents
toxin activity by binding to it. Type II TA systems have been found in both bacteria and
archaea and many species contain more than one TA system. The toxins function in a
variety of ways, including controlling gene expression by inhibiting transcription or
translation, and controlling cell growth by inhibiting peptidoglycan synthesis (Syed et al
2012). These systems typically respond quickly because of the labile nature of the antitoxin.
Under normal conditions, the anti-toxin and the toxin form a stable complex that
inhibits the toxin function, but many TA complexes also auto-regulate their own
expression. When a bacterial cell encounters environmental stress, general proteases,
such as Lon and Clp, become active and the anti-toxin is quickly degraded. The toxin is
more stable and is not as readily degraded. Once the toxin is active, gene expression of
the TA system increases and the toxin is free to perform its task.
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The oral cavity is an environment that experiences constant change due to the
intake of food, beverages, and the constant flow of saliva. Normal consumption of food
and drink can result in changes in temperature, pH, osmotic conditions and nutrients. It is
feasible that bacteria within the oral cavity utilize TA systems to temporarily alter cell
growth to adapt to environmental stress. The presence of TA systems in A.
actinomycetemcomitans has not been fully investigated as of yet.

Results
A. actinomycetemcomitans growth is affected by environmental stress:
To determine the effects of environmental stress on wild-type bacteria, A.
actinomycetemcomitans was grown in CDM under one of five stress conditions for 48
hours. The five test conditions were: iron limitation (250 μM bipyridyl), aerobic (no
added carbon dioxide), anaerobic, and microaerophilic (5% carbon dioxide) conditions,
and reduced temperature (30oC). In Figure 7, bacteria growing in aerobic conditions
exhibit a doubling time of approximately two hours. Doubling time has previously be
calculated within the laboratory and these growth curves are consistent with those assays
(data not shown). Iron limitation reduced the OD600 at stationary phase but had little
effect on doubling time. One possible explanation for this is that A.
actinomycetemcomitans is able to store iron for use when it cannot acquire iron from its
environment (Fong et al 2003). Reduced temperature and anaerobic conditions did not
significantly affect the growth of the bacteria when supplemented with glucose,
suggesting that bacteria adapt rapidly to these conditions. Growth under microaerophilic
conditions also reduces the OD600 at stationary phase, but doubling time is also
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unaffected . Taken together, these results suggest that A. actinomycetemcomitans is
capable of efficiently responding to environmental stress.
Since previous studies show that A. actinomycetemcomitans prefers to utilize
lactate as a carbon source, cells were also cultured in CDM that was supplemented with
lactate instead of glucose. As shown in Figure 8, doubling time in CDM/lactate increased
to four hours and cell density began to drop significantly after 48 hrs. Utilization of
lactate under anaerobic or microaerophilic conditions resulted in a loss of cell density
after 24 hours.
CDM itself is hypotonic and contains only 100 mg/L (1.7 mM) of sodium
chloride, whereas BHI contains 5.0 g/L (85mM). To determine if salt concentration
influences the growth of A. actinomycetemcomitans, cultures were grown in CDM with
increasing concentrations of sodium chloride. As shown in Figure 9, sodium chloride
concentration in CDM has little effect on growth. However, the growth of bacteria in BHI
when compared to the growth in CDM with additional sodium chloride is still greater,
indicating that the growth difference is not due to osmotic stress.
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were analyzed using a two-tailed t-test. *** p<0.001. Error bars were omitted to ensure all data points can be seen.

different stress conditions in triplicate. Growth was measured by reading the absorbance of the culture at OD600. Final OD600 values

Figure 7. Growth of bacteria under environmental stress. Bacteria were grown in CDM with glucose for at least 48 hours under
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p<0.01, *** p <0.001

environmental stressors. Growth was measured by absorbance at OD600. Results were analyzed using an unpaired t-test * p<0.05, **

Figure 8. Growth of bacteria with lactate and environmental stress. Bacteria were grown in CDM with lactate under different

unpaired t-test * p<0.05, ** p<0.01, *** p <0.001. Error bars were omitted to ensure all data points can be seen.

environmental stress conditions in triplicate. Growth was measured by absorbance at OD600. Final OD600 were analyzed using an

Figure 8. Growth of bacteria with lactate and environmental stress. Bacteria were grown in CDM with lactate under different
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Error bars were omitted to ensure all data points can be seen.

absorbance of the culture at OD600. There were no statistically differences between the control CDM and any of the test CDMs.

growth differences between CDM and BHI was due to osmotic stress in triplicate. Growth was measured by reading the

Figure 9. Growth of bacteria in osmotic stress. Bacteria were grown in CDM with glucose and added salt to determine if the

BLAST results for type II toxin/anti-toxin systems in A. actinomycetemcomitans:
Type II TA systems encode two small proteins (each between 41-206 amino
acids) that can regulate bacterial cell function. Previous studies have shown that TA
systems are involved with biofilms, antibiotic stress, and starvation (Horak et al 2017).
To determine if the A. actinomycetemcomitans genome encodes type II TA systems,
protein sequences of known type II TA systems found in E. coli were used to perform
BLAST searches of the A. actinomycetemcomitans D11S-1 genome (Chen et al 2009).
Table 8 shows the results of these BLAST searches. The BLAST searches identified nine
putative TA systems. Two have homology to the MazEF-family, which inhibit translation
through endoribonuclease activity that cleaves mRNA independently of ribosome
binding. One TA system has homology to HipAB-family, which inhibits translation
through a serine/threonine kinase that targets tRNA. The remaining six putative TA
systems exhibit homology to the RelBE-family, which cleave mRNA, but
endoribonuclease activity of these TA systems is ribosome dependent.
Since approximately 32% of the genes in A. actinomycetemcomitans do not have
a known function, it is possible that unique TA systems may exist that were not identified
in the BLAST searches. To address this possibility, the entire genome was examined
using TAfinder to identify two gene operons that encode small proteins in the size range
of known toxin and anti-toxin proteins. Five additional putative TA systems were
identified from this search. Using the protein sequence of these genes, a BLAST search
was performed and no significant results for known TA systems were found, suggesting
that these five putative TA systems may be unique to A. actinomycetemcomitans. In
addition, D11S_0469-0470 and D11S_2094-2095 were unique in that each putative TA
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system contains a third open reading frame, which encodes a gene unrelated to the toxins
or antitoxins, with homology to diadenosine tetraphosphatase and O-succinylbenzoate
synthase, respectively. Finally, sequence analysis suggested that three of the putative TA
systems may contain pseudogenes (indicated by an asterisk in Table 8). Hence, the A.
actinomycetemcomitans D11S-1 genome encodes at least 14 putative type II TA loci,
three of which may contain pseudogenes and may be non-functional.
There are currently seven recognized serotypes of A. actinomycetemcomitans and
there are marked differences in their ability to cause disease (Minquez et al 2014, Brigido
et al 2014). Using the sequences from E. coli toxin and anti-toxin protein sequences
described above, BLAST searches were performed across 33 A. actinomycetemcomitans
genome sequences present in the NCBI database. Table 9A-G summarizes the results of
these searches. Each ‘X’ in the chart indicates a BLAST match that showed sequence
similarity across the entire probe peptide sequence. A majority of the A.
actinomycetemcomitans strains examined possess only the TA systems that were
identified in the initial BLAST search of the D11S-1 genome. None of the other E. coli
TA systems were found in the A. actinomycetemcomitans genome sequences tested, with
the exception of the presence of a TA system related to E. coli yncN in two serotype c
strains of A. actinomycetemcomitans (SCC2302 and AAS4A). In addition, several
serotype d and e strains lack homology to several E. coli systems, e.g., strain SA2200
serotype d lacks homologs of PemK, ChpBK and YafO (see Table 7D). Finally, the
HipA toxin is a large protein compared to many other toxins classified as type II TA
systems. Many of the homologs found in A. actinomycetemcomitans are annotated as
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Table 8. Type II TA systems identified in A. actinomycetemcomitans D11S-1 using BLAST and
TAFinder.
AntiTotal
Query
Max
Toxin
Gene Identity
Family
E Value
toxin
Score
Cover
Identity
mazF

mazE

D11S_0905-0906

mazEF

101

92%

2e-28

33%

chpBK

chpBI

D11S_0919-0920

mazEF

88.6

93%

2e-23

42%

hipA

hipB

D11S_1069-1070

hipAB

108

21%

1e-28

45%

yafQ

dinJ

D11S_1194-1195

relBE

89.7

95%

2e-24

36%

yoeB

yafM

D11S-1718-1719

relBE

125

100%

1e-38

63%

relE

relB

D11S_1798-1799

relBE

112

94%

6e-33

57%

relE

relB

D11S_2133-2134

relBE *

44.7

88%

2e-7

12%

relE

relB

D11S_1417-1418

relBE

102

98%

3e-30

54%

relE

relB

D11S_1144-1145

relBE

149

97%

2e-46

59%

D11S_1023-1024
D11S_0150-0151

*

D11S_0499-0500

*

D11S_0469-0470

**

D11S_2094-2095

**

* - sequence analysis indicated this operon contained a toxin and/or antitoxin pseudogene
** - identified by TAfinder but present in a 3 gene operon with a non-TA related gene (see text)
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O - only the anti-toxin gene is present 1 - partial sequence match 2 - internal deletion in toxin open reading frame 3 - frameshift
mutation in toxin open reading frame 4- toxin only
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O - only the anti-toxin gene is present 1 - partial sequence match 2 - internal deletion in toxin open reading frame 3 - frameshift
mutation in toxin open reading frame 4- toxin only
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O - only the anti-toxin gene is present 1 - partial sequence match 2 - internal deletion in toxin open reading frame 3 - frameshift
mutation in toxin open reading frame 4- toxin only
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O - only the anti-toxin gene is present 1 - partial sequence match 2 - internal deletion in toxin open reading frame 3 frameshift mutation in toxin open reading frame 4- toxin only
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O - only the anti-toxin gene is present 1 - partial sequence match 2 - internal deletion in toxin open reading frame 3 frameshift mutation in toxin open reading frame 4- toxin only
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O - only the anti-toxin gene is present 1 - putative pseudogene Copyright permission to reuse granted by the Creative
Commons Attribution License (Schneider et al 2018).
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O - only the anti-toxin gene is present 1 - putative pseudogene Copyright permission to reuse granted by the Creative
Commons Attribution License (Schneider et al 2018).
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O - only the anti-toxin gene is present 1 - putative pseudogene Copyright permission to reuse granted by the Creative
Commons Attribution License (Schneider et al 2018).
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O - only the anti-toxin gene is present 1 - putative pseudogene Copyright permission to reuse granted by the Creative
Commons Attribution License (Schneider et al 2018).
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O - only the anti-toxin gene is present 1 - putative pseudogene Copyright permission to reuse granted by the Creative
Commons Attribution License (Schneider et al 2018).

smaller proteins and are usually present as multiple open reading frames that are
identified as hipA-like. It is likely that these sequences in A. actinomycetemcomitans
represent a hipA gene that has undergone deletion or rearrangement during its evolution.
A second BLAST search was performed using the sequences identified in D11S-1
to determine if the type II TA systems identified in the D11S_1 strain are conserved in
other strains within the C serotype, as well as across all known serotypes. As shown in
Tables 10A – E, most of the D11S-1 TA systems are highly conserved across all of the
other A. actinomycetemcomitans serotypes. Two exceptions were D11S_150-151 and
D11S_1069-1070. A complete D11S_1069-1070 operon was present in only three of the
33 strains examined (D11S-1, Sc383s and ANH9381); the other strains either lacked the
toxin open reading frame or possessed a truncated gene, but interestingly most contained
the anti-toxin gene. D11S_150-151 was present in all serotype a, b, d, f and g strains but
was absent in the serotype c organisms except for D11S-1 which possessed a truncated
pseudogene. For many of the strains across all of the serotypes, some TA systems were
present in multiple copies. For example, serotype b strain RhAA1 possesses at least 19
TA systems including two copies of D11S_0469-0470, D11S_0905-0906, D11S_14181419 and D11S_2133-2134, and three copies of D11S_1023-1024 and D11S_1798-1799,
yet this strain also lacked D11S_1069-1070, D11S_1194-1195, and D11S_2094-2095.
Finally, PCR reactions using A. actinomycetemcomitans 652 (serotype c) DNA as a
template indicated that all of the D11S-1 TA systems were present (not shown).
Although a complete genome sequence is not yet available, strain 652 has been
extensively characterized in our laboratory and was used for the functional
characterization of the A. actinomycetemcomitans TA systems described below. Overall,
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these results suggest that the TA systems identified in the D11S-1 genome are highly
conserved in all A. actinomycetemcomitans serotypes suggesting that they may play an
important role in A. actinomycetemcomitans physiology. However, D11S_150-151 and
D11S_1069-1070 were more limited in distribution than the other TA systems.

Putative TA systems in A. actinomycetemcomitans respond to environmental stress.
Previous work done within the laboratory and elsewhere has shown that A.
actinomycetemcomitans growth is influenced by environmental stress, such as iron
starvation or pH and temperature fluctuations (data not shown). Since it is possible that
TA systems are responsible for controlling bacterial growth when activated, mRNA
expression of the putative TA systems was examined under different stress conditions.
During normal cell activity, the anti-toxin is bound to the toxin. This inhibits toxin
activity and in many cases, the complex of the two proteins has been shown to autoregulate its own operon expression by binding to the promoter. When cells experience
environmental stress, general proteases such as the Lon and Clp proteases are activated
and the labile anti-toxin is rapidly degraded which de-represses operon expression.
To assess the effect of environmental stress on TA expression, wild-type bacteria
were grown to mid-exponential phase and cells were exposed to various stress conditions
for 20 minutes and then harvested for RNA extraction. RNA was converted into cDNA
and the cDNA was analyzed via real-time PCR to determine changes in TA gene
expression change.
Figure 10A displays the results obtained for the three of putative TA systems that
were unique to A. actinomycetemcomitans. D11S_0150-0151 was upregulated under
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anaerobic (no oxygen) and under iron limiting (250μM bipyridyl) conditions, and slightly
under acidic stress (pH 5.0). The other two systems showed very little change from the
control, however, D11S_0499-0500 was down-regulated under acidic (pH 5.0) and in the
presence of hydrogen peroxide (0.1% hydrogen peroxide).
Figure 10B shows the HipAB homolog was largely unresponsive to most stress
conditions tested. However, there was an induction in expression of this TA operon when
the cells were cultured under anaerobic conditions and when the cells were exposed to
elevated temperature (39oC).
Figure 10C focuses on the two putative systems with homology to MazEF-family
systems. Interestingly, both systems exhibit a similar pattern of expression. Both systems
also show large up-regulation under microaerophilic (5% carbon dioxide) and anaerobic
conditions, and to a lesser extent under acidic stress (pH 5.0) and when lactate is the
carbon source. Since these systems were activated in almost all stress conditions tested,
with the exception of oxidative stress (0.1% hydrogen peroxide), these systems may aid
in the adaption of the bacteria to a variety of environmental stimuli. These results also
suggest functional redundancy may exist in the MazEF-like systems since both respond at
similar levels to environmental stress.
Figure 10D focuses on four of the five RelBE-family homologs. There is a
significant up-regulation of two of the systems under acidic conditions (pH 5.0), but the
other two systems were not as responsive. One system was induced under iron starvation
(250μM bipyridyl) but the other three systems were not responsive under this condition.
Three of the systems experienced a large up-regulation under anaerobic conditions, but
one was not responsive. For oxidative stress (0.1% hydrogen peroxide), microaerophilic

63

(5% carbon dioxide), elevated temperature (39oC), lactate for a carbon source, and
reduced temperature (30oC), all of the systems were not responsive.
The results taken together suggest that the putative TA systems differentially
respond to environmental stress and clearly, not all systems respond to every stress.
Seven of the 11 systems compromising members of each of the TA families were induced
under anaerobic conditions, suggesting that a high degree of functional redundancy may
exist in the TA systems contributing to adaption to anaerobic growth. In contrast, only
two systems were significantly induced when cultures were either grown under
microaerophilic conditions, acidic conditions, or under iron limiting conditions, which
suggests that some TA systems are functionally more specific. Only one of the TA
systems, D11S_1023-1024, did not respond to any of the environmental stress conditions
that were tested.
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Figure 10A-D. Induction of type II TA system expression in A. actinomycetemcomitans exposed to various environmental
conditions. A. TA systems with no known homology. B. TA system related to the HipAB family. C. TA systems related to the
MazEF family. D. TA systems related to the RelBE family. Copyright permission to reuse granted by the Creative Commons
Attribution License (Schneider et al 2018).

CHAPTER FOUR: GENERATION AND CHARACTERIZATION OF ISOGENIC
DELETION MUTANTS

Introduction
As A. actinomycetemcomitans enters stationary phase, the pH of medium drops
from an initial pH of 7.5 to approximately a pH of 5.5 - 6.0 in stationary phase,
depending on the medium used for culture. Previous work showed that when the pH of
spent medium was adjusted back to neutral, A. actinomycetemcomitans continued to grow
without

any

other

additives

(Bhattacharjee

2011),

suggesting

that

A.

actinomycetemcomitans entrance into stationary phase may be dependent on
environmental pH rather than the lack of nutrients.
Two of the putative TA systems were highly responsive to acidic stress, which
suggests that these systems may be important for overall fitness of the bacteria under
acidic conditions. Since the pH of the gingival pocket can vary significantly, it is possible
that these two systems are important for colonization and maintenance of biofilms in the
oral cavity. Some studies have shown that removal of TA systems in bacteria has a
noticeable effect on biofilm formation and stability (Yamaguchi et al 2009). Since the
presence of a biofilm in the gingival crevice is crucial for progression of disease, these
two systems in A. actinomycetemcomitans were chosen for further studies.
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Results
Generation of isogenic deletion mutants:
Using a suicide vector that was previously designed in the laboratory, two
isogenic mutants were created. The suicide vector contains two separate selection
mechanisms: the first is to permit the identification of single recombination events that
incorporate the plasmid into A. actinomycetemcomitans genome (Campbell 1957) and
subsequently to isolate mutants that have undergone a second recombination that results
in deletion of the target gene and the loss of the plasmid sequences. This results in a
markerless and scarless deletion mutant. Colonies that appeared to have experienced two
recombination events were analyzed with PCR to determine if the gene of interest was
deleted (Figure 11A-B).
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Figure 11A-B. PCR of isogenic mutants to show gene deletion. A) Lane 1 is the
ladder, labeled in kDa. Lane 5 and 6 are the Δ1194-1195 mutants and Lanes 7 and 8 are
the wild-type. B) Lane 1 is wild-type, lane 3 is the Δ1718-1719 mutant, and lane 7 is the
ladder.
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Metabolic activity at stationary phase decreases over time.
Previous work showed that viable wild-type A. actinomycetemcomitans could be
recovered from broth cultures for up to a week after entering stationary phase, when the
cultures were maintained at room temperature (Bhattacharjee 2011). As A.
actinomycetemcomitans grows into stationary phase in BHI broth, the pH of the medium
drops from approximately 7.5 to near 5.0 in 24 hours. The pH of the medium is
maintained over time and there is no difference between the wild-type strain and two
isogenic mutants(data not shown). Since the two putative TA systems chosen for further
analysis were responsive to acidic conditions, cell viability in stationary phase was
determined using a MTT assay.
As shown in Figure 12A, the wild-type strain maintains a steady loss of metabolic
activity over 120 hours. The Δ1718/1719 is the more sensitive to sustained exposure to
acidic conditions in stationary phase and lost metabolic activity to a greater extent than
the wild-type, especially between 72 and 120 hours. Complementation of the deletion
mutant with a functional copy of D11S_1718-1719 restored the metabolic activity to
wild-type levels. The Δ1194-1195 mutant phenotype was similar to the wild-type strain
through 72 hours, but exhibited a significant decrease in metabolic activity relative to the
wild-type strain at 96 and 120-hour time points (Figure 12B). Complementation of the
mutant restored metabolic activity to the wild-type level. Interestingly, the OD600 of the
cultures did not significantly decrease over the incubation period for any of the strains
(data not shown), suggesting that cell lysis may not be occurring as metabolic activity
decreases.
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Figure 12A-B. Metabolic activity of stationary phase A. actinomycetemcomitans.
Metabolic activity was measured using a MTT assay. Asterisks indicate the time points
where metabolic activity of the mutant strain was significantly reduced relative to the
wild-type (P ≤ 0.05) and restored to wild-type levels when complemented with a
functional copy of the TA system. Copyright permission to reuse granted by the Creative
Commons Attribution License (Schneider et al 2018).

70

Isogenic mutants exhibit reduced biofilm growth
Type II TA systems have been implicated in biofilm formation in various
bacterial species (Cardenas-Mondragon et al 2016, Wood et al 2016, Sun et al 2017,
Schneider et al 2018). A. actinomycetemcomitans is an oral commensal that forms
biofilms within the gingival pocket. Biofilms are important for survival of the bacteria
within the oral cavity and necessary for disease progression.
To determine if the type II TA systems of interest are involved in biofilm
formation, biofilms were grown in multi-well cell culture plates using BHI. Static
biofilms were allowed to grow untouched for 72 hours and then provided with fresh
medium at pH 5.0 to pH 8.0. After incubation for an additional 24 hours, biofilms were
quantified by crystal violet staining. Figure 13 shows that biofilm biomass of the wildtype strain increased after the addition of fresh medium at pH 6.0, 7.0, or 8.0, consistent
with previous findings of Bhattacharjee et al. However, a significant decrease in biomass
occurred when the wild-type biofilm was incubated in fresh medium at pH 5.0. Biomass
of the Δ1718-1719 strain was significantly less than that of the wild-type at pH 5.0 and
6.0, but was restored to wild-type levels when the deletion strain was complemented with
a function copy of the TA system. Biomass of the Δ1194-1195 strain did not differ
significantly from wild-type; however, complementation of the strain resulted in a
significant increase (P ≤ 0.01) in biofilm biomass relative to the wild-type at pH 5.0 and
pH 6.0, possibly arising from the presence of the TA system in multiple copy in the
complemented strain. Together, these results suggest that the putative TA systems may
contribute to the persistence of A. actinomycetemcomitans in mature biofilms exposed to
acidic conditions.
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Figure 13A-B. 72 hour biofilms are sensitive to pH stress. Biofilms were allowed to
grow for 72 hours before media was refed with fresh BHI at pH 5.0 to pH 8.0. Biomass
was quantified after staining with crystal violet. Control is a biofilm that was not refed
with fresh medium. Asterisks indicate conditions where biofilm biomass of the mutant
strain was significantly reduced (P ≤ 0.05) relative to the wild-type strain and restored to
near wild-type levels after complementation. Copyright permission to reuse granted by
the Creative Commons Attribution License (Schneider et al 2018).
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CHAPTER FIVE: PUTATIVE TOXIN/ANTI-TOXIN SYSTEMS INHBIT
TRANSLATION AND FUNCTION AS AN ENDORIBONUCLEASE

Introduction
Type II TA systems encode two proteins, the toxin and the anti-toxin. The toxin
has a biologically relevant function that is necessary for the survival of the cell under
environmental stress. The two systems that have been chosen for further analysis,
D11S_1194-1195 and D11S_1718-1719 both belong to the RelBE-family of TA systems.
Goltfredsen et al first identified relEB has a toxin/anti-toxin gene family where the
induction of the RelE protein was resulted in an inhibition of growth that was prevented
in the presence of the RelB (Goltfredsen et al 1998). Since then, the relEB has been
shown to be a type II toxin/anti-toxin system where the RelE protein is a toxin that binds
to the bacterial ribosomes to cleave mRNA in A-site of the ribosome in a sequence
specific manner (Galvani et al 2001, Pedersen et al 2003). RelEB has specifically been
implicated in apoptosis in human cells, adaption of pathogens to macrophages, antibiotic
resistance, and persister cell formation (Yamamoto et al 2002, Korch et al 2009, Singh et
al 2010, Tashiro et al 2012). Interestingly, the anti-toxin, RelB, has been shown to form
a dimer is able to bind to the operator region of its own operon to repress its own
expression and this autorepression is enhanced in the presence of the toxin protein (Li et
al 2008, Overgaard et al 2009).
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RelEB-like systems have been shown to differentially respond to environmental
stressors, such as amino acid starvation, glucose starvation, and oxidative stress (Averina
et al 2015, Christensen-Dalsgaard et al 2010, Yang et al 2012, Marsan et al 2017). Based
on the real-time PCR data shown previously, two of the RelEB-like homologs were able
to respond acidic pH stress. Deletion of D11S_1718-1719 results in a more rapid loss of
cell metabolic activity after cells enter stationary phase, suggesting that this TA system
plays an important role in maintaining cellular fitness during stationary phase; deletion of
D11S_1718-1719 also resulted in a loss of biomass of mature biofilms when exposed to
acidic stress conditions. To determine if these putative type II TA systems act at the level
of translation, as many other RelBE TA systems do, and function as endoribonucleases,
the functional properties of purified proteins representing full-length toxin and antiproteins were examined.

Results
Inducible expression of putative TA system
To determine if the genes of interest truly encode TA systems, expression of the
proteins by an inducible plasmid was carried out. The toxin only and anti-toxin only were
cloned separately into pQE60, an inducible vector for expression of proteins in E.coli that
produces proteins containing a C-terminal hexa-histidine fusion tag.
Initial experiments to express the TA system proteins showed that the tagged
proteins were present in the insoluble fraction after cell lysis, but not likely in an
inclusion body since it could be made partially soluble in low molarity solutions of urea
(Figure 14A). There are many protocols suggesting a variety of methods to increase
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solubility without the need to use a denaturant, including using a lower temperature for
induction of expression, using more sonication buffer during lysis, and altering the buffer
composition (i.e. increase salt concentration). Dialysis can be a long, difficult process to
refold protein. While many companies offer membranes with an appropriate molecular
weight cut off (MWCO), small proteins may be susceptible to degradation during this
process, so other non-denaturing methods were considered and tested.
The most successful method to drive protein into the soluble fraction was to use a
two-step sonication. Using a standard sonication buffer (50 mM phosphate, pH 7.8, 300
mM NaCl), the samples were sonicated and then pelleted. The supernatant was removed
into a clean tube for further use and the pellet was suspended in fresh sonication buffer.
The pellet was sonicated for a second time and pelleted again. Most of the tagged protein
was present in the soluble fraction (Figure 14B) using this method.
The soluble protein obtained through this method did not bind to the metal affinity
agarose beads commonly used to purify histidine tagged proteins. All of the His-tagged
protein eluted in the initial flow through after allowing time for the protein to bind to the
beads (data not shown). One explanation for this is that the His-tag is sterically shielded
from interacting with the affinity resin. Since sonication and purification worked under
denaturing conditions, samples were sonicated in protein buffer containing 0.1% SDS.
The SDS denatures the proteins and this percentage is compatible with the affinity
purification procedure. To verify this was effective, cultures of E. coli were induced at
37oC until late exponential phase. Cells were harvested and the pellet was suspended in
the denaturing sonication buffer for lysis. The lysate was centrifuged to remove insoluble
debris and the supernatant was purified using the cobalt agarose resin. Figure 15 shows

75

two representative dot blots of the purification process. Samples were refolded as
described using 2-MPD and then samples were concentrated. Elution samples were
analyzed on Bis-Tris SDS-PAGE gels (Figure 16).
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Figure 14A-B. Putative TA systems can be expressed in an inducible plasmid.
Western blot of crude protein extract following Bis-Tris SDS-PAGE. A) Crude protein
extract following lysis with sonication. Lanes 1 – Ladder, 2-1194 soluble,3- 1194
insoluble, 4-1194 4M Urea soluble, 5-1194 4M Urea insoluble, 6-1719 soluble, 7-1719
insoluble, 8-1719 4M urea soluble, 9-1719 4M Urea insoluble B) Crude protein extract
following lysis with two separate sonication steps. 1-3: 1194 soluble, 4-6: 1719 soluble,
7-9: 1194 insoluble, 10-12: 1719 insoluble, 13- Ladder
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Figure 15. Dot Blot after purification on agarose beads. Representative dot blot of
1194 (A) and 1195 (B)after SDS denaturation. SDS denatured proteins were purified
using cobalt agarose beads. Each square represents a sample of fluid collected during the
purification process. 1: Flow-through after initial binding period; 2: Wash Step #1 – 0
mM imidazole; 3: Wash Step #2 – 0 mM imidazole; 4: Wash Step #3 – 0 mM imidazole;
5: Elution #1 – 10 mM imidazole; 6: Elution #2 – 100 mM imidazole; 7: Elution #3 – 200
mM imidazole; 8: Elution #4 – 400 mM imidazole
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Figure 16. Toxin proteins after refolding and concentration. Lane 1 is empty, Lane 2
is 1194, Lane 3 is 1719, Lane 4 is empty and Lane 5 is the Ladder. Representative SDSPAGE gel to show that soluble protein remained after purification, refolding, and
desalting. Arrow indicates where the protein of interest is located.
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Putative toxins inhibit protein synthesis and degrade mRNA:
RelE-like proteins are able to inhibit translation by cleaving mRNA. To determine
if the putative toxins of interest act in a similar manner, the ability of the toxins to
degrade mRNA was characterized. Initial tests (data not shown) showed that the purified
protein obtained from expression in E. coli had RNase contamination that was not fully
inhibited by traditional inhibitors. To ensure RNAse free protein, synthetic peptides were
produced by Biosynthesis, Inc. and were analyzed for purity by gel electrophoresis
(Figure 17).
These peptides were tested for inhibition of translation using the PURExpress In
Vitro Protein Synthesis system and a control plasmid that expresses mRNA encoding
dihydrofolate reductase (DHFR). Synthetic peptide was added at 200 ng to the translation
reaction (or 100 ng of each when mixtures were analyzed). The reaction was allowed to
incubate for two hours before being analyzed on a Tris-Glycine SDS-PAGE gel (Figure
18). As shown in Figure 18, DHFR (indicated by a white arrow in Lanes 1 and 8) is
readily produced when the control translation reaction was carried out in the absence of
synthetic peptide. In contrast, no DHFR is produced when the reaction is conducted in the
presence of the synthetic 1194 toxin (Lane 2). DHFR production is unaffected by the
synthetic 1195 anti-toxin peptide (Lane 3) or by the presence of equal amounts of both
the synthetic 1194 toxin and 1195 anti-toxin (Lane 4). This result indicates that the
synthetic 1194 peptide functions as a toxin that inhibits DHFR translation and that the
1195 protein represents its corresponding anti-toxin that is capable of preventing toxin
activity when applied together.
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Similarly, synthetic 1718 protein prevents translation of DHFR (Lane 5) whereas
the 1719 peptide or an equal mixture of 1718 and 1719 proteins have no effect on DHFR
production (Lanes 6 and 7, respectively). This result was unexpected since from the
structural organization of many RelBE TA operons, the open reading frame encoding the
1719 protein would be predicted to encode the toxin component. Our results clearly show
that 1719 does not inhibit DHFR translation and thus functions as an anti-toxin and that
the 1718 peptide represents the toxin in this TA system.
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Figure 17. Synthesized peptides are the correct size for the proteins of interest.
Peptidess were dissolved in protein buffer containing 0.01% TFA. Samples need the TFA
to go completely into solution. Samples were analyzed with a Bis-Tris SDS-PAGE gel.
Lane 1 – Ladder, Lane 2- 1194, Lane 3-1195, Lane 4 – 1194/1195 together, Lane 51718, Lane 6- 1719, Lane 7 – 1718/1719 together
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Figure 18. In vitro translation of DHFR in the presence of synthetic peptides. TrisGlycine SDS-PAGE gel of in vitro translation samples that were incubated with the toxin
or anti-toxin proteins of the TA system, either alone or in combination. Lane 1 – positive
control (no inhibition), Lane 2 – 1194 only, Lane 3 – 1195 only, Lane 4- 1194/1195
together, Lane 5 – 1718 only, Lane 6 – 1719 only, Lane 7 – 1718/1719 together, Lane 8 –
Positive Control, Lane 9 – empty, Lane 10 – ladder. Arrow marks the positive control
protein. Copyright permission to reuse granted by the Creative Commons Attribution
License (Schneider et al 2018).
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To examine the mechanism of translation inhibition, we next determined if the
toxin proteins function as a ribosome dependent ribonuclease. To accomplish this,
purified ribosomes were mixed with bacteriophage MS2 RNA (MS2 contains a positivesense, single stranded RNA genome), and synthetic toxin and/or anti-toxin proteins,
incubated at 370C for 25 minutes and electrophoresed in a TBE-Urea gel. As shown in
Lane 1 of Figure 19A, MS2 RNA exhibits only minor degradation in the absence of
ribosomes and synthetic protein. In contrast, Figure 19B shows that MS2 RNA is
significantly degraded in the presence of ribosomes and synthetic 1194 peptide (Lane 2)
but not by synthetic 1195 or an equimolar mixture of 1194 and 1195 peptides (Lanes 3
and 4, respectively). Similarly, addition of ribosomes and synthetic 1718 results in MS2
degradation (Lane 5) whereas little degradation is observed in the presence of 1719 or a
mixture of 1718 and 1719 proteins (Lanes 6 and 7, respectively). These results are
consistent with the translation inhibition results and strongly suggest that the 1194 and
1718 toxins function as ribosome dependent endoribonucleases, which are inhibited by
the 1195 and 1719 anti-toxin proteins.
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Figure 19A-B. MS2 RNA degradation occurs in the presence of ribosomes. RNA
samples were incubated in the presence or absence of ribosomes and were analyzed on a
TBE-Urea gel stained with ethidium bromide. Lane 1: Control – no toxin or anti-toxin
proteins; Lane 2: D11S_1194 toxin only; Lane 3: D11S_1195 anti-toxin only; Lane 4:
equal mixture of D11S_1194 and 1195; Lane 5: D11S_1718 toxin only; Lane 6:
D11S_1719 anti-toxin only; Lane 7: equal mixture of D11S_1718 and 1719. Copyright
permission to reuse granted by the Creative Commons Attribution License (Schneider et
al 2018).
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Putative toxins and associated anti-toxins interact and bind to each other:
An important aspect of the TA system is that the type II TA systems are
composed of two small proteins in which the anti-toxin inhibits the activity of the toxin
by directly binding to the toxin. To further demonstrate this interaction, the proteins were
analyzed by FPLC. The peptides were solubilized the day of the experiments by
suspending the peptide in HPLC grade PBS with 1% TFA and mixed before loading. The
column was standardized using a variety of markers before the protein samples were
loaded on to the column (data not shown). There is a large peak at 10 mL, which
corresponds to the size of the individual peptides. However, there is a second peak that is
observed at 20mL, which represents the size if protein or protein complex with a
molecular weight 2-fold greater than the monomer (Figure 20A). Since both proteins in
the TA system are approximately the same size, this peak likely represents a dimer of
toxin and anti-toxin. The size of this second peak is small, suggesting that under these
conditions, dimer formation may not be favored.
The D11S_1718-1719 mix shows three peaks: one near where each monomer
peptides elute, and a third peak that represents the proteins binding (Figure 20B). As seen
with the D11S-1194-1195 system, the peak that corresponds to a complex appears to
indicate a weak interaction between the two proteins under these conditions. The
presence of three peaks and the low mAU readings in the D11S_1718-1719 are both
likely to do incomplete solubility of the peptides in the solutions needed for the FPLC.
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indicates where a protein complex would appear.

together for analysis. B: equal concentrations of 1718 and 1719 mixed together for analysis. The smaller peak for each pair

Peptides were dissolved in HPLC grade PBS buffer containing 1% TFA. A: equal concentrations of 1194 and 1195 mixed

Figure 20A-B. FPLC results for peptide mixtures. Purified, synthesized peptides were analyzed for interactions using FPLC.

CHAPTER SIX: EVALUATION OF PROTEOME UNDER STRESS

Introduction
As previously shown, the two TA systems are ribosome-dependent
endoribonucleases that likely cleaves mRNA to inhibit protein translation. Many
examples of type II TA toxins show that recognition of mRNA is sequence specific and
that these sequences are found throughout most of the genome. Since many bacteria
contain a multiple type II TA systems that can differentially respond to environmental
cues, it is likely that different proteins are required to adapt to the local environment. The
two type II TA systems of interest in this study are from the same family of systems and
they respond to some of the same environmental stressors in the similar manner,
suggesting that they may affect the proteome in a similar manner under certain stress
conditions.
Cultures of wild-type and both isogenic deletion mutants were grown to mid-log
phase in CDM and then gently pelleted. The medium was decanted and the pellet was
suspended in fresh CDM at either pH 7.0 or pH 5.0. The cultures were then allowed to
grow for four hours or two doubling periods. Cultures were once again gently pelleted
and suspended in a protein lysis buffer containing 8M Urea.
Samples were sent to the Proteomics core at the University of Louisville for
analysis via liquid chromatography-tandem mass spectrometry (LC-MS/MS) on an LTQOrbitrap. Briefly, the denatured proteins were processed within the core facility by
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trypsin digestion to form smaller peptides. Peptides were first separated using liquid
chromatography. After elution, the samples were then subjected to an ionization source
and the particles were analyzed by mass spectroscopy. The LTQ-Orbitrap utilizes a
quadrupole to process the charged particles. The first quadropole allows certain sized
particles through into the collision cell. Here, the particles are further fragmented before
being sent to another quadrupole for further analysis. After the entire sample has been
processed, software is able to identify the peptide fragments after comparison to the
protein database and to quantitate the proteins that were present in the sample. Fold
change was determined by comparing the number of times a specific protein was
identified within wild-type to the number of times it was found in a mutant.

Results
Δ1194-1195 Mutant vs Wild-Type
The Δ1194-1195 mutant had 58 proteins that were differentially represented when
compared to wild-type: 43 were over-represented and 15 were under-represented (Table
11A and 11B). Of the 43 proteins that were over-represented, four were not detected
within the wild-type sample. The majority of the over-represented proteins were involved
in metabolism: 25% are involved in amino acid metabolism, and 25% are involved in
nucleotide metabolism (Figure 21A-B). Proteins involved in virulence and transport
across the membrane are the next two most common groups of proteins over-represented
(19% each), followed by proteins involved in membrane formation (12%). Two of the
proteins identified have no known function at this time. Since the toxins of these TA
systems work by acting as endoribonucleases, it can be suggested that the activation of
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the toxin results in the degradation of ribosome-associated mRNA in the wild type strain,
which results in a decrease in translation of specific gene products. Our results suggest
that the D11S_1194-1195 TA system, under acidic stress, targets the mRNAs encoding
the proteins identified above to enable survival.
On the other hand, there are 15 proteins that are under-represented in the mutant
when compared to wild-type. Seven of the 15 proteins that were under-represented were
not detected within the mutant. As with the over-represented proteins, the majority of the
proteins affected are involved in metabolism; two of which are involved in the synthesis
of molecules that are secreted (Figure 22A-B). Proteins involved in transcription are the
second most affected by the absence of the D11S_1194-1195 TA system. There are a
variety of reasons that these proteins could be under-represented, including gene
regulation of the identified proteins by the anti-toxin or the toxin/anti-toxin complex, or
the activation of other TA systems to compensate for the loss in the mutant.
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Table 11A. Proteins over-represented in Δ1194-1195 vs Wild-type
Fold
Gene Name
Accession Number
Change
AsnC

tr|C9R706|C9R706_AGGAD

2.048150677

N-acetylmuramoyl-L-alanine amidase

tr|C9R3G4|C9R3G4_AGGAD

2.04816057

tRNA-specific 2-thiouridylase MnmA
Short-chain dehydrogenase of various
substrate specificities
Cytochrome D ubiquinol oxidase,
subunit II
Uncharacterized protein

tr|C9R2L0|C9R2L0_AGGAD

2.048171276

tr|C9R2U6|C9R2U6_AGGAD

2.048178364

tr|C9R5W5|C9R5W5_AGGAD

2.048183128

tr|C9R2Q7|C9R2Q7_AGGAD

2.048186174

Putative GTP cyclohydrolase 1 type 2
HTH-type transcriptional regulator
MalT
Conserved ABC-type transport system
protein, ATPase component
MdlB protein
Molybdopterin biosynthesis MoeA
protein
Tellurite resistance protein TehB

tr|C9R3S8|C9R3S8_AGGAD

2.048186591

tr|C9R480|C9R480_AGGAD

2.0481882

tr|C9R4W3|C9R4W3_AGGAD

2.048200208

tr|C9R1V9|C9R1V9_AGGAD

2.048200995

tr|C9R3L9|C9R3L9_AGGAD

2.048203593

tr|C9R481|C9R481_AGGAD

2.048204445

D-ribose transporter subunit RbsB

tr|C9R6M8|C9R6M8_AGGAD

2.048205478

Uridine kinase

tr|C9R397|C9R397_AGGAD

2.048205996

Lipoprotein, putative
Acetyl-coenzyme A carboxylase
carboxyl transferase subunit beta
Sodium/proline symporter

tr|C9R5G6|C9R5G6_AGGAD

2.048207305

tr|C9R4D5|C9R4D5_AGGAD

2.048207976

tr|C9R3A6|C9R3A6_AGGAD

2.048213425

Anaerobic C4-dicarboxylate transporter
Glycerol-3-phosphate transporter (G-3P transporter) (G-3-P permease)
Succinyl-diaminopimelate
desuccinylase
Coproporphyrinogen-III oxidase

tr|C9R1M8|C9R1M8_AGGAD

2.048213537

tr|C9R5Y5|C9R5Y5_AGGAD

2.048214244

tr|C9R308|C9R308_AGGAD

2.048215854

tr|C9R6L7|C9R6L7_AGGAD

2.048220049

ABC transporter, ATP-binding protein

tr|C9R4W0|C9R4W0_AGGAD

2.048223512

Integration host factor subunit alpha

tr|C9R4L0|C9R4L0_AGGAD

2.048225273

AcrA protein

tr|C9R4I9|C9R4I9_AGGAD

2.048228579

Alpha/beta superfamily hydrolase

tr|C9R4E8|C9R4E8_AGGAD

2.048229416

Transport associated protein 4

tr|D0UIW9|D0UIW9_AGGAD

2.04824494

Lipoprotein, putative

tr|C9R5U7|C9R5U7_AGGAD

2.048252468
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Table 11A. Proteins over-represented in Δ 1194-1195 vs Wild-type, Continued
Fold
Gene Name
Accession Number
Change
Opacity-associated protein OapB

tr|C9R653|C9R653_AGGAD

2.048259203

Biotin synthase

tr|C9R407|C9R407_AGGAD

2.048303541

50S ribosomal protein L28

tr|C9R211|C9R211_AGGAD

2.048311174

Shikimate 5-dehydrogenase

tr|C9R1M6|C9R1M6_AGGAD

3.072280136

Uncharacterized protein

tr|C9R586|C9R586_AGGAD

3.0722832

Hemolysin

tr|C9R260|C9R260_AGGAD

3.072302014

Conserved outer membrane protein
Inosine-5'-monophosphate
dehydrogenase
UDP-N-acetylmuramoyl-L-alanyl-Dglutamate--2,6-diaminopimelate ligase
Putative integrase

tr|C9R2Q8|C9R2Q8_AGGAD

3.072350744

tr|C9R3E7|C9R3E7_AGGAD

3.072384397

tr|C9R2Z2|C9R2Z2_AGGAD

3.072384397

tr|C9R439|C9R439_AGGAD

3.072408089

Adenylosuccinate lyase
Dihydrolipoyllysine-residue
succinyltransferase component of 2oxoglutarate dehydrogenase complex

tr|C9R251|C9R251_AGGAD

3.584469387

tr|C9R5N0|C9R5N0_AGGAD

4.09647951

PotD protein

tr|C9R463|C9R463_AGGAD

Fructose-1,6-bisphosphatase class 1

tr|C9R630|C9R630_AGGAD

Lipopolysaccharide assembly protein B

tr|C9R5A2|C9R5A2_AGGAD

Nodulation efficiency protein D (NfeD)

tr|C9R5E8|C9R5E8_AGGAD
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Not Detected
in WT
Not Detected
in WT
Not Detected
in WT
Not Detected
in WT

Table 11B. Proteins underrepresented in Δ1194-1195 vs Wild-type
Gene Name

Accession Number

Fold Change

Cell division protein ZapA

tr|C9R1Y4|C9R1Y4_AGGAD

0.256027213

RNA polymerase sigma factor
ATP-dependent RNA helicase
SrmB
Methionine import ATPbinding protein MetN
30S ribosomal protein S15
Outer membrane protein
assembly factor BamD
Macrolide export ATPbinding/permease protein
MacB
Ferric uptake regulation
protein (Ferric uptake
regulator)
Amylovoran biosynthesis
glycosyltransferase AmsE
PEBP family protein

tr|C9R2V1|C9R2V1_AGGAD

0.341358857

tr|C9R7E4|C9R7E4_AGGAD

0.341363892

tr|C9R779|C9R779_AGGAD

0.341368982

tr|C9R6D9|C9R6D9_AGGAD

0.341384509

tr|C9R1Y6|C9R1Y6_AGGAD

0.409630534

tr|C9R4F0|C9R4F0_AGGAD

0.409646276

tr|C9R597|C9R597_AGGAD

0.438899439

tr|C9R5I9|C9R5I9_AGGAD

Not Detected

tr|C9R782|C9R782_AGGAD

Not Detected

Shikimate 5-dehydrogenase

tr|C9R3U7|C9R3U7_AGGAD

Not Detected

DNA-binding protein

tr|C9R4U2|C9R4U2_AGGAD

Not Detected

Sugar efflux transporter
tr|C9R399|C9R399_AGGAD
UDP-3-O-acylglucosamine Ntr|C9R1I0|C9R1I0_AGGAD
acyltransferase
Phosphohistidine phosphatase
tr|C9R3E0|C9R3E0_AGGAD
SixA

Not Detected

92

Not Detected
Not Detected
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Figure 21A. Proteins Over-Represented in Δ1194-1195. The proteins that were identified as being over-represented when
compared to wild-type are grouped based on the function of the protein.
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Figure 21B. Breakdown of the over-represented metabolism proteins in Δ1194-1195. The proteins identified as being
involved in metabolism are further characterized based on the metabolic process involved.
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Figure 22A. Proteins underrepresented in Δ1194-1195 vs Wild-Type. Proteins identified as underrepresented when
compared to the wild-type sample grouped by general protein function.
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Figure 22B. Breakdown of the underrepresented metabolism proteins in Δ1194-1195. The proteins identified as being
involved in metabolism are further characterized based on the metabolic process involved.

Δ1718-1719 vs Mutant
The Δ1718-1719 isogenic mutant had 92 identified proteins as being differentially
represented when compared to the wild-type. Unlike the Δ1194-1195, many of the
proteins identified were underrepresented rather than over-represented. Of the 92
proteins, 38 are over-represented and 54 were underrepresented (Table 12A-B). Of the 38
proteins that are over-represented, six were not detected in the wild-type sample. As seen
in the Δ1194-1195 mutant, the majority of the over-represented proteins identified are
involved in metabolism: 22% involved in nucleotide metabolism and 21% involved in
amino acid metabolism (Figure 23A-B). Unique to the Δ1718-1719 mutant, is the
involvement of nitrogen metabolism. The protein that was identified is related to the
cytochromes c-type protein, NrfB, in E. coli. NrfB is a protein that is involved in nitrite
reduction and is involved in the electron transport chain under anaerobic conditions. This
is followed by proteins involved in virulence (18%), transport across the membrane
(11%), membrane formation (8%), and translation (8%). There are also two proteins
identified that have no known function at this time. It is highly probable that the
activation of the D11S_1718-1719 TA system results in the degradation of the ribosomeassociated mRNA for these proteins to enhance survival. This is also consistent with the
real-time PCR data which suggests that the two TA systems respond to some of the same
environmental conditions. Importantly, the D11S_1718-1719 system was responsive to
anaerobic stress whereas the D11S_1194-1195 system was not, which is consistent with
the inclusion of nitrogen metabolism proteins seen in the Δ1718-1719 mutant.
The Δ1718-1719 deletion mutant exhibited many more proteins that are
underrepresented compared to the over-represented. Of the 54 proteins identified, 20
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were present in wild type but were not detected in the mutant sample. These proteins are
involved with many different pathways including iron transport, LPS synthesis, cell
formation, stationary phase survival, and type IV secretion. The majority of the identified
proteins were involved in metabolism: 16% involved in amino acid metabolism and 11%
each for nucleotide and carbohydrate metabolism (Figure 24A-B). As seen in the overrepresented proteins, we also see the involvement of nitrogen metabolism. This protein is
identified as another cytochrome c-type protein, but instead of being involved in the
electron transport chain, this protein is involved in the denitrification pathway, which is
the reduction of nitrate to dinitrogen, which can in turn act as a terminal acceptor for
electron transport in place of oxygen.
The lack of so many metabolism genes, compared to the Δ1194-1195, strain is
consistent with the loss of metabolic activity seen over time in stationary phase.
Following metabolism, proteins involved in transport across the membrane (13%),
virulence (11%), and replication (9%) are the next most identified proteins. Also of
interest, 9% of the underrepresented proteins in this strain have no known function.
Taken together, these results appear to be consistent with the phenotype seen in mutant’s
ability to survive stationary phase and resist acidic stress.
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Table 12A. Proteins over-represented in Δ1718-1719 vs Wild-Type
Gene Name

Accession Number

Fold Change

HTH-type transcriptional regulator MalT

tr|C9R480|C9R480_AGGAD

2.33323847

tRNA-specific 2-thiouridylase MnmA
Cytochrome c nitrite reductase,
pentaheme subunit
Molybdopterin biosynthesis MoeA
protein
Tellurite resistance protein TehB
Acetyl-coenzyme A carboxylase carboxyl
transferase subunit beta
Mannonate dehydratase

tr|C9R2L0|C9R2L0_AGGAD

2.33326575

tr|C9R6A6|C9R6A6_AGGAD

2.333270941

tr|C9R3L9|C9R3L9_AGGAD

2.3332763

tr|C9R481|C9R481_AGGAD

2.33328287

tr|C9R4D5|C9R4D5_AGGAD

2.33329127

tr|C9R506|C9R506_AGGAD

2.33329162

Putative GTP cyclohydrolase 1 type 2

tr|C9R3S8|C9R3S8_AGGAD

2.3332931

Anaerobic C4-dicarboxylate transporter
Conserved ABC-type transport system
protein, ATPase component
Alanine racemase

tr|C9R1M8|C9R1M8_AGGAD

2.33330228

tr|C9R4W3|C9R4W3_AGGAD

2.33330528

tr|C9R3J0|C9R3J0_AGGAD

2.33330792

7-cyano-7-deazaguanine synthase

tr|C9R316|C9R316_AGGAD

2.333308559

Chaperone protein HscA homolog

tr|C9R384|C9R384_AGGAD

2.333311488

Methyltransferase domain family
Putative N-acetylmannosamine-6phosphate 2-epimerase
Trk system potassium uptake protein
TrkA (K(+)-uptake protein trkA
Succinyl-diaminopimelate desuccinylase
Dihydrolipoyllysine-residue
succinyltransferase component of 2oxoglutarate dehydrogenase complex
Guanylate kinase
UDP-N-acetylmuramoyl-L-alanyl-Dglutamate--2,6-diaminopimelate ligase
Phosphohistidine phosphatase SixA

tr|C9R693|C9R693_AGGAD

2.333315617

tr|C9R562|C9R562_AGGAD

2.333316888

tr|C9R719|C9R719_AGGAD

2.33331717

tr|C9R308|C9R308_AGGAD

2.33332003

tr|C9R5N0|C9R5N0_AGGAD

2.3333477

tr|C9R4V0|C9R4V0_AGGAD

2.333348296

tr|C9R2Z2|C9R2Z2_AGGAD

2.33335056

tr|C9R3E0|C9R3E0_AGGAD

2.333355213

50S ribosomal protein L31

tr|C9R205|C9R205_AGGAD

2.333358038

50S ribosomal protein L28

tr|C9R211|C9R211_AGGAD

2.33338839

HemY protein

tr|C9R2R4|C9R2R4_AGGAD

2.333406739

ABC transporter, ATP-binding protein
MdlB protein

tr|C9R4W0|C9R4W0_AGGA
D
tr|C9R1V9|C9R1V9_AGGAD
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2.91662946
3.49985374

Table 12A. Proteins over-represented in Δ1718-1719 vs Wild-Type (continued)
Gene Name

Accession Number

Fold Change

Uncharacterized protein

tr|C9R586|C9R586_AGGAD

3.49990112

Conserved outer membrane protein

tr|C9R2Q8|C9R2Q8_AGGAD

3.49996723

Hemolysin
Inosine-5'-monophosphate
dehydrogenase
Heavy metal-binding protein, putative
Phenylalanine--tRNA ligase alpha
subunit

tr|C9R260|C9R260_AGGAD

3.49997777

tr|C9R3E7|C9R3E7_AGGAD

3.50002583

tr|C9R6G6|C9R6G6_AGGAD

3.50003706

tr|C9R4L2|C9R4L2_AGGAD

4.666829217

Capsular polysaccharide synthesis

tr|C9R202|C9R202_AGGAD

Excinuclease ABC subunit B

tr|C9R1Y9|C9R1Y9_AGGAD

UvrABC system protein B

tr|C9R568|C9R568_AGGAD

Fructose-1,6-bisphosphatase class 1

tr|C9R630|C9R630_AGGAD

Lipopolysaccharide assembly protein
B
Nodulation efficiency protein D
(NfeD)

tr|C9R5A2|C9R5A2_AGGAD
tr|C9R5E8|C9R5E8_AGGAD
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Not Detected
in WT
Not Detected
in WT
Not Detected
in WT
Not Detected
in WT
Not Detected
in WT
Not Detected
in WT

Table 12B. Proteins under-represented in Δ1718-1719 vs Wild-Type
Gene Name
Macrolide export ATP-binding/permease
protein MacB
UPF0319 protein D11S_1646

Accession Number

Fold
Change

tr|C9R4F0|C9R4F0_AGGAD

0.2333297

tr|C9R5C4|C9R5C4_AGGAD

0.233334914

Ribulose-phosphate 3-epimerase

tr|C9R1U2|C9R1U2_AGGAD

0.291658268

Cytochrome c-type protein
ATP-dependent Clp protease ATP-binding
subunit ClpX
UPF0250 protein D11S_2139

tr|C9R7G9|C9R7G9_AGGAD

0.291662013

tr|C9R6G1|C9R6G1_AGGAD

0.291667122

tr|C9R6Q4|C9R6Q4_AGGAD

0.291669942

Putrescine-binding periplasmic protein

tr|C9R1Q1|C9R1Q1_AGGAD

0.3181806

30S ribosomal protein S15

tr|C9R6D9|C9R6D9_AGGAD

0.38887493

Glycerol-3-phosphate transporter

tr|C9R1W9|C9R1W9_AGGAD

0.388877596

RNA polymerase sigma factor

tr|C9R2V1|C9R2V1_AGGAD

0.3888784

Uncharacterized protein

tr|C9R1K0|C9R1K0_AGGAD

0.388879949

Opacity-associated protein OapA

tr|C9R654|C9R654_AGGAD

0.388880892

Regulator of ribonuclease activity B
Membrane-bound lytic murein
transglycosylase A (Murein hydrolase A)
(Mlt38)
Putative aldolase YneB

tr|C9R717|C9R717_AGGAD

0.388880984

tr|C9R632|C9R632_AGGAD

0.388883054

tr|C9R4N8|C9R4N8_AGGAD

0.388883164

Aldo/keto reductase

tr|C9R2N9|C9R2N9_AGGAD

0.38888338

Uridine phosphorylase

tr|C9R707|C9R707_AGGAD

0.388883454

Uncharacterized protein

tr|C9R3M9|C9R3M9_AGGAD

0.388883823

Possible AAA+ superfamily ATPase

tr|C9R317|C9R317_AGGAD

0.388884928

TadZ

tr|C9R2X0|C9R2X0_AGGAD

0.388886689

Chromosomal replication initiation protein
Phosphatidylserine decarboxylase
proenzyme
Uncharacterized protein

tr|C9R6K4|C9R6K4_AGGAD

0.388887077

tr|C9R6S9|C9R6S9_AGGAD

0.388887189

tr|D0UIV3|D0UIV3_AGGAD

0.38888734

GTP cyclohydrolase-2

tr|C9R5H0|C9R5H0_AGGAD

0.388888038

Cell division protein ZipA homolog

tr|C9R520|C9R520_AGGAD

0.388888889

Queuine tRNA-ribosyltransferase
Outer membrane protein assembly factor
BamD
Ribonucleoside-diphosphate reductase

tr|C9R5T0|C9R5T0_AGGAD

0.437498099

tr|C9R1Y6|C9R1Y6_AGGAD

0.46664817

tr|C9R3K2|C9R3K2_AGGAD

0.466655995

Phosphate transport regulator

tr|C9R5Q5|C9R5Q5_AGGAD

0.466660286
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Table 12B. Proteins under-represented in Δ1718-1719 vs Wild-Type (continued)
Fold
Gene Name
Accession Number
Change
tRNA uridine 5carboxymethylaminomethyl modification
enzyme MnmG
Aspartate--ammonia ligase

tr|C9R1N8|C9R1N8_AGGAD

0.466663115

tr|C9R705|C9R705_AGGAD

0.466668996

Lipoprotein, putative

tr|C9R2X8|C9R2X8_AGGAD

0.466673217

30S ribosomal protein S6

tr|C9R1W3|C9R1W3_AGGAD

0.466684313

Mannose-specific PTS system protein IID

tr|C9R1Q9|C9R1Q9_AGGAD

Aminotransferase, class-V

tr|C9R5E2|C9R5E2_AGGAD

Not Detected

Apolipoprotein N-acyltransferase
Cluster of Binding-protein-dependent
transport systems inner membrane
component
Cystathionine beta-lyase

tr|C9R373|C9R373_AGGAD

Not Detected

tr|C9R394|C9R394_AGGAD

Not Detected

tr|C9R3C3|C9R3C3_AGGAD

Not Detected

D-3-phosphoglycerate dehydrogenase
Enoyl-[acyl-carrier-protein] reductase
[NADH]
Iron-sulfur cluster insertion protein ErpA

tr|C9R2I2|C9R2I2_AGGAD

Not Detected

tr|C9R3S7|C9R3S7_AGGAD

Not Detected

tr|C9R533|C9R533_AGGAD

Not Detected

L-asparaginase, putative

tr|C9R6E4|C9R6E4_AGGAD

Not Detected

Long-chain-fatty-acid--CoA ligase

tr|C9R5F5|C9R5F5_AGGAD

Not Detected

Mce related protein

tr|C9R5N9|C9R5N9_AGGAD

Not Detected

N utilization substance protein B homolog
Nicotinamide-nucleotide
adenylyltransferase
Possible heptosyltransferase II (Inner core)

tr|C9R3J3|C9R3J3_AGGAD

Not Detected

tr|C9R2F0|C9R2F0_AGGAD

Not Detected

tr|C9R207|C9R207_AGGAD

Not Detected

Putative transport protein D11S_0239

tr|C9R7K3|C9R7K3_AGGAD

Not Detected

DNA-binding protein

tr|C9R4U2|C9R4U2_AGGAD

Not Detected

Sugar efflux transporter
UDP-3-O-acylglucosamine Nacyltransferase
Glycerol-3-phosphate transporter (G-3-P
transporter) (G-3-P permease)
Alpha/beta superfamily hydrolase

tr|C9R399|C9R399_AGGAD

Not Detected

tr|C9R1I0|C9R1I0_AGGAD

Not Detected

Transport associated protein 4

0.5

tr|C9R5Y5|C9R5Y5_AGGAD

Not Detected

tr|C9R4E8|C9R4E8_AGGAD

Not Detected

tr|D0UIW9|D0UIW9_AGGAD

Not Detected
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Figure 23A. Proteins Over-Represented in Δ1718-1719. The proteins that were identified as being over-represented when
compared to wild-type are grouped based on the function of the protein.
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Figure 23B. Breakdown of the over-represented metabolism proteins in Δ1718-1719. The proteins identified as being
involved in metabolism are further characterized based on the metabolic process involved.
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Figure 24A. Proteins underrepresented in Δ1718-1719. The proteins that were identified as being over-represented
when compared to wild-type are grouped based on the function of the protein.
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Figure 24B. Breakdown of the underrepresented metabolism proteins in Δ1718-1719. The proteins identified as
being involved in metabolism are further characterized based on the metabolic process involved.

Δ1194-1195 vs Δ1718-1719
Since the real-time PCR data suggests that some functional redundancy between
the two putative TA systems, the proteomics data was also analyzed to compare the two
mutant strains to each other (Figure 25). In total, 120 proteins were identified as being
differentially represented when compared to wild-type. Of these, 34 were common to
both mutant strains: 23 over-represented, 7 underrepresented, and four differentially
represented. This data further supports the hypothesis that TA systems in the same family
may exhibit some level of functional redundancy. It is also interesting that 59
differentially represented proteins are unique to the Δ1718-1719 mutant strain, of which
15 are over-represented and 44 are under-represented relative to the wild type strain.
Twenty-seven differentially represented proteins are unique to the Δ1194-1195 mutant
strain, of which 20 are over-represented and 7 are under-represented relative to the wild
type. These results confirm that functional redundancy exists for these TA systems but
also clearly suggests that each TA system may also have specific functions, which is
consistent with the phenotypic differences seen in these strains.
Looking at just the proteins that are represented in both isogenic deletion strains,
proteins involved in metabolism and virulence are the most prevalent, and represent more
than 50% of the differentially represented proteins when compared to wild-type. Of the
metabolism proteins identified, amino acid metabolism was the most common pathway
affected. It is also interesting to point out that all of the proteins that are found in both
mutant strains have known functions.
Examining the unique proteins to each strain, the majority (42%) of the proteins
identified in the Δ1718-1719 strain are involved in metabolism (Figure 27A-B). The
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majority of these metabolism proteins are involved in various general pathways, but
nucleotide metabolism is the most common affected. The next most prevalent group is
proteins with no known function (12%), followed by transport across the membrane and
virulence (9% each). While metabolism is still the majority of identified proteins in the
Δ1194-1195 strain, transport across the membrane is the next largest group, followed by
proteins involved in transcription and membrane formation (Figure 28A-B). The majority
of the metabolism proteins in the Δ1194-1195 strain are general enzymes, there’s only
two other groups identified: amino acid and nucleotide metabolism. Both of which are
equally represented.
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Figure 25. Comparison of proteomics data between two isogenic mutants. Total proteins identified as being differentially
expressed were compared to determine similarities between the two isogenic mutants.
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broken down by protein function.

Figure 26A. Total proteins identified. The total number of unique proteins identified through the proteomics analysis
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on pathways involved.

proteins that were identified as being shared between the two mutants, the metabolism proteins were further grouped based

Figure 26B. Breakdown of metabolism proteins in common between two isogenic mutants. Among the identified
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based on function of the protein.

Figure 27A. Identified proteins unique to Δ1718-1719. Proteins identified as being unique to Δ1718-1719 are grouped
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Δ1718-1719 isogenic mutant were further grouped based on pathways involved.

Figure 27B. Breakdown of metabolism proteins unique to Δ1718-1719. Identified metabolism proteins that are unique to the
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based on protein function.

Figure 28A. Identified proteins unique to Δ1194-1195. Proteins identified as being unique to Δ1194-1195 are grouped
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the Δ1194-1195 isogenic deletion mutant are further grouped based on pathway involved.

Figure 28B. Breakdown of identified metabolism proteins unique to Δ1194-1195. Identified proteins that are unique to

CHAPTER SEVEN: DISCUSSION
Type II TA systems are one way that bacteria and archaea have evolved to
respond rapidly to changing environments. The oral cavity is a constantly changing
environment that is affected by everything that we eat and drink, saliva, and oral hygiene
products. In order to sustain life in this environment, bacteria will grow in biofilms
attached to the tooth surface. Biofilms are able to limit the effects of some of these stress
conditions by creating gradients that make the bacteria resistant to changes. There is also
substantial evidence that bacteria that are susceptible to a particular antibiotic in
planktonic culture may exhibit resistance in a biofilm, yet the role that type II TA systems
play in the response of oral organisms to stress is largely unknown.
Here, we showed that an oral commensal with potential to be an opportunistic
pathogen, A. actinomycetemcomitans, contains 14 putative TA loci that represent at least
three of the six known families of type II TA systems. Three of these loci possess
pseudogenes that have experienced partial gene deletion or rearrangement and these three
systems are likely non-functional. Two of the systems identified in strain D11S-1 were
not widely conserved across all seven serotypes. Of the 33 genomes examined, all three
contained an intact HipAB-like system and 22 of the remaining genomes contained only
the anti-toxin. Interestingly, most the 33 genomes examined were derived from human
isolates, but many of the identified putative TA systems are conserved in the RhAA1
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strain, which was isolated from the oral cavity of a rhesus monkey. The RhAA1 strain
also contains more copies of the type II TA systems than any of the other strains, which
may reflect the ability of this strain to adapt to environmental stress conditions that exist
within the rhesus monkey oral cavity.
A. actinomycetemcomitans, is able to respond to environmental stress. Some
environmental conditions effect the growth of the bacteria. As with many human
pathogens, A. actinomycetemcomitans has an iron requirement and iron starvation slows
growth. Since A. actinomycetemcomitans prefers to utilize lactate as a carbon source
(Brown et al 2007) and that lactic acid is produced by many of the oral streptococci in the
oral cavity, it is interesting that when an iron chelator was added to the medium, it
appeared to have no effect on growth when lactate was the carbon source. When the iron
chelator bipyridyl, which is used in many commercially available colorimetric assays to
determine concentration of iron in samples, is added to a medium that contains iron, the
medium changes color as the iron is bound. The bipyridyl interacts with iron (II) to form
a complex containing one iron ion connected covalently to 3 bipyridyl molecules that
results in a red color being observed: the more intense the color, the more iron that is
present in the solution (Kaes et al 2000). When bipyridyl was added to CDM containing
lactate and iron, no color change was observed, but when it is added to CDM containing
glucose and iron, the medium turns bright pink. One possible explanation for this is that
lactate can complex with iron (Ali et al 2000) and thus lowers the concentration of iron
that is available to the chelator. Also of interest is the effect that carbon dioxide has on
growth since A. actinomycetemcomitans needs carbon dioxide to grow on plates.
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The presence of type II TA systems in the genome of A. actinomycetemcomitans
represents one mechanism for bacteria to respond and adapt quickly to the environmental
changes. The presence of multiple systems in the genome is not unusual, but many
species do not contain any of these systems and some species have dozens of copies.
Previous studies have shown that TA systems can cross-talk by a variety of mechanisms
including activating the transcription of other systems, anti-toxin inhibition of noncognate toxins, or enhancing the activity of other systems (Yang et al 2010, Kasari et al
2013). When considering the real-time PCR data to determine transcription levels of the
putative TA systems, there were several TA systems that appeared to be largely
unresponsive to the conditions tested. Two of the TA systems that were unique to A.
actinomycetemcomitans exhibited little to no activation of transcription when exposed to
the environmental conditions tested. One explanation for this result is that these systems
respond to an environmental stimulus that was not tested in our approach. A more
common pattern observed across all families of the type II TA systems identified was that
each system responded highly to only one or two stress conditions, but was largely
unresponsive to others. This suggests that specificity exists in the response of various
members of the TA system repertoire of A. actinomycetemcomitans in that specific TA
systems respond to the greatest extent to certain environmental conditions. However, our
data also shows that many of the putative type II TA systems respond at least partially to
many of the stress conditions tested. Interestingly, putative TA systems within a family
appeared to exhibit functional redundancy. For example, the two systems in the MazEF
family exhibited similar levels of activation across all conditions. This functional
redundancy would protect against the loss of one system to ensure survival, which also
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suggests these systems are important for the survival and adaption to the environment
within the oral cavity.
It is not currently clear how this specificity to environmental stress exists. Briefly,
the inhibition of the type II TA system is due to the presence of the anti-toxin, which can
inhibit the toxin’s activity and represses the systems transcription by binding to the
promoter region (Muthuramalingam et al 2016, Hayes et al 2014). To activate the
system, general ATP-dependent bacterial proteases, such as Lon and Clp, will readily
degrade the anti-toxin, thus depleting the cellular concentration of it and causing the
activation of the toxin (Muthuramalingam et al 2016, Hayes et al 2014, Gerdes 2000).
However, these are general proteases and they are responsible for a large percentage of
the protein degradation within the cell (Muthuramalingam et al 2016, Van Melderen et al
2009). Interestingly, anti-toxins have been experimentally been shown to be substrates
for Lon, however, it is has not been demonstrated in vivo. These same studies also
indicate the activation of type II TA systems is more complex than a single protease
degrading the anti-toxin, and more importantly, the reason for specificity of a response to
a stressor has not been elucidated at present (Sat et al 2001, Christensen et al 2001,
Muthuramalingam et al 2016). It is possible that the anti-toxin only interacts with the
protease under certain circumstances, such as stress, and cell density, or that the stressor
causes the anti-toxin to become unfolded, thus activating the proteases (Micevski et al
2013, Muthuramalingam et al 2016, Yang et al 2016, Gur 2013).
Wild-type bacteria exhibit reduced metabolic activity over the course of a week
at stationary phase; the loss in activity was fairly steady from day to day. The Δ11941195 mutant was able to survive at stationary phase, but experienced a significant drop in
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metabolic activity after 96 hours. This suggests that the loss of this TA system may affect
viability at stationary phase. Similar results were obtained with the Δ1718-1719 mutant
but to a greater extent. This isogenic deletion mutant was much more susceptible to
acidic pH in stationary phase when compared to wild-type; loss of metabolic activity was
observed as early as 24 hours and was very evident at 72 hours. One possible explanation
for this observation is that the activity of the D11S_1718-1719 TA system may
effectively compensate for the loss of the D11S_1194-1194 system, however, the activity
the D11S_1194-1194 system may not fully compensate for deletion of D11S_1718-1719.
This is consistent with functional redundancy between the two systems and the loss of the
D11S_1194-1195 system is not sufficient to greatly affect the overall metabolic activity
of the bacteria. Similar functional redundancy has been observed in TA systems of other
organisms. It has been shown in a strain of E. coli that possesses five TA systems that the
loss of a single TA system had no impact on the fitness of the bacteria (Tsilibaris et al
2007. However, another study went a step further and deleted all five TA systems and
observed a phenotype when the bacteria were grown in a biofilm (Wang et al 2011). In A.
actinomycetemcomitans, the generation of a double mutant was attempted multiple times,
but was unsuccessful, which suggests that these systems are important for survival and
that deletion of both may be lethal. It is also interesting to note that the D11S_1718-1719
TA system was present in all 33 genome sequences of A. actinomycetemcomitans that
were analyzed for presence of TA systems, but the D11S_1194-1195 was not present in
all genomes. This could also indicate the importance of the D11S_1718-1719 in the
overall fitness of the bacteria since its deletion was difficult to achieve and the deletion
showed the greatest phenotype.
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Both mutant strains also exhibited reduced biofilm biomass relative to the wild
type when mature biofilms were exposed to acidic conditions and this phenotype was
complemented with functional copies of the TA systems. Importantly, initial biofilm
formation of the mutant strains was similar to wild-type, indicating that the mutants are
not deficient in the ability to form a biofilm. This is consistent with our earlier results
showing that both systems may function to preserve metabolic activity during stationary
phase.
To further examine the function of the acid responsive TA systems, the activity of
the individual toxin and anti-toxin proteins was determined. Since the TA systems chosen
for further study are both RelBE-like homologs, we surmised that these putative systems
may represent endoribonucleases that are dependent on the ribosome for activity. In vitro
translation experiments using a control plasmid with a known protein product showed
that both purified toxins inhibited translation and that the anti-toxins had no effect on
translation. In addition, when toxin and anti-toxin were mixed together in equimolar
amounts, the activity of the toxin was inhibited and no effect on translation was observed.
In many cases, the anti-toxin is encoded by the first gene in the operon and the toxin by
the second. However, Figure 20 clearly shows that 1718 behaves as a toxin and 1719
behaves as an anti-toxin. This is further supported by the mRNA degradation assay using
MS2 bacteriophage genomic RNA (Figure 21). There are a few examples of this in the
literature. It does not appear that function is affected by this reversal and phenotypes that
have been seen are very similar to the phenotypes seen in the “normal” TA systems.
(Budde et al 2007, Christensen-Dalsgaard et al 2009, Jorgensen et al 2009, Jurenas et al
2017) The most noted example of this rearrangement is seen in higBA, where higB is the
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toxin. HigBA belongs to a family of TA systems that resemble RelBE because it is an
endoribonuclease that is dependent on the ribosome to function. Budde et al showed that
deletion of higB only was possible, but deletion of higA was not possible. They also
showed that activation of the HigB toxin resulted in slowed growth, but was not
associated with cell death. Christensen-Dalsgaard et al also suggests that higBA is relBE,
but in reverse. Taken together, our results suggest that the putative toxins degrade mRNA
in the presence of ribosomes and inhibit translation. This activity is prevented by the
cognate anti-toxin proteins and thus, both systems appear to function as RelBE-like TA
systems, regardless of the gene order.
Proteomic analyses of the mutant and wild type strains identified differentially
represented proteins that were common to the two mutants, but also a significant number
of polypeptides that were unique to each mutant strain. This further supports the idea that
multiple TA systems within a family may have functional redundancy, but are also able
to differentially respond to different environmental cues. This is highlighted, in part, by
the presence of the nitrogen metabolism proteins being identified in the Δ1718-1719
mutant and not the Δ1194-1195 mutant. Furthermore, the real-time PCR data indicated
that the D11S_1718-1719 TA system was responsive to anaerobic stress while the
D11S_1194-1195 TA system was not.
There are a wide variety of pathways that are affected by the presence of these
systems, including virulence factors such as leukotoxin, which was over-represented in
the mutants. This suggests that the expression of the leukotoxin may be regulated in part
by the endoribonuclease activity of the toxins in the wild-type strain. Since the leukotoxin
is an important virulence factor associated with aggressive periodontitis, it is possible that
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exploitation of the TA system could be used to potentially target leukotoxin expression
and reduce the potential for the bacteria to cause disease. It is also interesting that
autoinducer-2 aldolase produced by A. actinomycetemcomitans is only affected by the
Δ1718-1718 isogenic mutant and was less abundant in the mutant. Since quorum sensing
is important in the formation of mature biofilms, this may explain in part why the Δ17181719 mutant exhibited reduced biofilm biomass after exposure to acidic conditions than
the Δ1194-1195 mutant. Another interesting finding was the presence of a type IV
secretion system component that was differentially expressed in the two mutants. BLAST
results suggest that this particular component has homology to the VirB5 protein family,
and that this particular protein is important for protein-protein interactions for pilus
assembly (Yeo et al 2003). This protein was not detected in the Δ1194-1195 mutant, but
was over-represented in the Δ1718-1719 mutant. Type IV secretion has not been well
studied in A. actinomycetemcomitans, but of the available literature, we know that A.
actinomycetemcomitans has a CagE-homolog, which is a protein that is commonly
associated with type IV secretion in other organisms and that this CagE protein may be
necessary to cause inflammation and tissue destruction in the host (Teng et al 2005). A
more recent study looked at the prevalence of type IV secretion systems in periodontitis
patients in Taiwan, and found that 90% of the samples with a complete type IV secretion
system module were from patients with localized aggressive periodontitis (Liu et al
2017). This suggests that the wild-type strain may also utilize the D11S_1718-1719 TA
system to aid in the invasion of surrounding host tissues and enable disease progression.
It is also important to note the proteomic analyses presented here were done on
planktonic cells, not biofilms. It is possible that different proteins may be affected during
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biofilm growth and thus it may be necessary to conduct the proteomic approach using
biofilm cells to fully understand how these TA systems alter the proteome of A.
actinomycetemcomitans exposed to acidic conditions. This is especially important since
type II TA systems have been directly implicated in the formation and stability of
biofilms in other bacterial species.
Targeting type II TA systems as a way to control bacterial growth has been
widely considered to result in the killing of the bacteria, without the need for antibiotics.
This would prevent the evolution of antibiotic resistance strains of bacteria, and hosts
may experience fewer side effects since humans appear to have no homologous proteins
(Park et al 2013, Unterholzner et al 2013, Williams et al 2012). It is possible that by
understanding how these systems respond to environmental stress and how they respond
within the cell, novel therapies that exploit these systems could be developed. Some
proposed methods of doing this involve chronic activation of the toxin, chronic activation
of the proteases, or complete inhibition of the toxin to prevent survival. These therapies
have the potential to be cost-effective to the consumer, in addition to being less painful
than current methods. These novel therapies may also be able to target multiple species at
once without difficulty.
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CHAPTER EIGHT: FUTURE DIRECTIONS
Persister Cell Formation and Anti-toxin Characterization:
One of the biggest questions in the literature of TA systems is: why do some
bacteria have multiple copies? Fasani et al suggest that one reason pathogenic bacteria
have so many copies is to increase the likelihood that persister cells will develop.
Persister cells cannot be identified through normal genomic methods since there is not a
gene associated with the ability to form this type of cell. Persister cells can be assayed for
by monitoring cell cultures for viability rather than metabolic activity. Many
commercially available kits exist that allow the identification of viable cells that may
otherwise be viewed as dead or dying. Preliminary tests within the laboratory suggest that
viability between wild-type strain and the two mutants may not be greatly affected over
time, but the assays still need to be optimized for use with A. actinomycetemcomitans.
Fasani et al also suggest that bacteria increase the likelihood for developing
persister cells by utilizing TA systems at different times and that they may use growth
rate as the signal for the activation. It is possible that this is why some of the putative TA
systems identified did not appear to be responsive to any of the environmental stressors
tested. It may be necessary to stress the bacteria for longer (or shorter) times or stress the
bacteria at different stages of growth. Initial tests in the laboratory attempted to collect
total RNA from early-log phase, mid-log phase, and late log phase for analysis.
Unfortunately, early and late log phase were difficult to isolate enough usable mRNA for

125

analysis using the cesium chloride method. Since these initial tests, a commercially
available kit for the isolation of mRNA from high lipid tissue culture has been
successfully used with better yields from less starting sample than the cesium chloride
method. It may be useful to repeat the real-time PCR assay using more time points, and
more primer sets for the untested putative TA systems.
The anti-toxin of the TA pair and the TA complex has been shown in many cases
to autoregulate the expression of the TA system, and in some cases to regulate the
expression of other genes within the genome. Examining the promoter region of the TA
operon and identifying the binding site for regulation will facilitate determining the
regulon for each of the TA systems and highlight how TA complexes affect gene
expression even when the toxin itself is not activated. TA-mediated regulation at the
transcriptional level may in part explain why the levels of some proteins were reduced in
the mutant strains.

Novel Therapies:
To exploit TA systems to develop potential novel therapies, we first need to
understand how the anti-toxin interacts with the toxin. Some 3D crystal structures have
already been determined, which can provide a starting point to determine what is actually
necessary for the toxin to be inhibited (Brown et al 2009, Francuski et al 2009, Shinohara
et al 2010, Bogglid et al 2012, Heaton et al 2012, Schureck et al 2014). After the
interaction of the toxin and anti-toxin has been elucidated more thoroughly, it may be
possible to develop small molecules or peptides that could potentially mimic this binding.
Since the anti-toxin is labile and is degraded easily, a presence of the mimic could
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prevent the activation of the toxin even in the absence of anti-toxin, thus making the
bacteria more susceptible to killing through biofilm disruption, antibiotics, or other
environmental stressors. We anticipate that this approach would inhibit adaptation of A.
actinomycetemcomitans to acidic conditions and may prevent the formation of persister
cells. By inhibiting toxin activation under acidic stress it is possible that infection could
be contained or eliminated without the need for an antibiotic or painful debridement.
It may also be possible to develop small molecules that inhibit the Lon and Clp
proteases, which initiate the activation of TA systems. This could prove to be a more
universal treatment pathway since more than one family of TA systems are activated by
these proteases and may be more conserved across species than the individual TA
systems. On the other hand, it may be possible to cause chronic activation of the toxin,
which would cause the bacteria to stop growing, and since it would not be turned off
under favorable conditions, it would eventually die. Small molecules may be developed
that can inhibit the activation of the TA operon, thus preventing more anti-toxin from
being transcribed and translated. Small molecules may also be able to developed that
cause the activation of the general proteases, which would keep the supply of the antitoxin low.

Other TA Systems and Stress:
Previous work in E. coli showed that a strain deficient in five TA systems was
deficient in antibiotic resistance, but only in the biofilm. It may be necessary to repeat the
proteomic assay done in this study with bacteria stressed in a biofilm. Optimization
would need to be done to determine how long to stress the biofilm for optimal results.
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There are multiple other TA systems that were not characterized during the initial
real-time PCR experiments. More insight into how these systems work and when they
work could be determined by repeating the assay here with more primer sets. Of the
systems that were characterized, there are many others that can be examined as well. Of
notable interest:
1. Iron Starvation
a. D11S_2133-2134
2. Anaerobic
a. D11S_2133-2134
b. D11S_1068-1069
c. D11S_0905-0906
d. D11S_0919-0920
e. D11S_1798-1799
3. Lactate as a carbon source
a. D11S_0905-0906
b. D11S_0919-0920
4. Microaerophilic Conditions
a. D11S_0905-0906
b. D11S_0919-0920
These conditions are important for survival in the oral cavity and should be
examined as well. Since only a handful of stress conditions were tested here, it is highly
probably that some of the unresponsive systems, such as D11S_0499-0500, and
D11S_1023-1024 have very specific stress conditions to which they respond. It is
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possible that one or more of these TA systems are utilized for the invasion of epithelial
cells and/or specifically when in a biofilm.
This will enhance our understanding of why some bacteria have multiple copies
of TA systems and will enable us to see how these systems cooperate with each other.

Other strains of A. actinomycetemcomitans:
Since a BLAST search showed that the type II TA systems found in strain D11S
were conserved across various serotypes, it may be of interest to examine the effects of
environmental stress in other serotypes, such as serotype A and B, which are also
associated with disease in humans. It would be important for the development of novel,
non-invasive therapies to determine if the type II TA systems being targeted are
responsive in all serotypes and how they are responsive.
Of interest as it relates to this study, serotypes D, E, F, and G all contain a HipAB
homolog when compared to the sequence in E. coli, but they do not contain of the HipAB
homolog found in D11S. Interestingly, these serotypes, while they can be found in human
oral cavities, are not typically associated with disease. The sequence in D11S appears to
have experienced a deletion event that broke the protein into two different genes. It
would be interesting to see what would happen with a full HipAB being introduced into
the strain used here. It would also be interesting to see how the D11S HipAB system
affects other strains with a full length HipAB system.
This will prove to be important when we look at the studies showing prevalence
of serotypes across a population around the world. Different serotypes are prevalent in
certain populations whereas others may not be found in certain areas.
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